???global.info.a_carregar???
Francisco Antunes, MD, PhD, Principal Investigator, has a large experience in the field of Infectious Diseases and Tropical Medicine, both national and internationally. In the past, he was the Director of the Department of Infectious Diseases and Full Professor of Medicine/Infectious Diseases in the larger University Hospital in Portugal (Centro Hospitalar Universitário Lisboa Norte). Also, he was Professor at the Tropical Medicine Institute, the only research and teaching institution for Tropical Medicine in Portugal, where he developed research on opportunistic parasites/fungi related with HIV patients, in particular in the field of Pneumocystis, Cryptosporidium, and Microsporidia. In PALOP (Mozambique, Angola, and S. Tomé e Principe) he organized several courses on HIV, TB and Hepatitis, and research in the fields of hepatitis, HIV and intestinal parasites. In the Department of Infectious Diseases at the Hospital de Santa Maria (Centro Hospitalar Universitário Lisboa Norte), he developed a number of studies, mainly on clinical trials of most of antiretrovirals recommended to ART, and on antiretroviral resistance and hepatitis B in Mozambique. Since 2013, he is the coordinator of the research group “Environment and Infectious Diseases” at the Institute of Environmental Health of the Lisbon School Medicine, and is the PI of two ongoing studies on the field of HCV, one of them on micro elimination of HCV, which received funding grants from the Industry of nearly 500.000€. He was President of the European Conference of HIV (EACS 1999), European Congress on Tropical Medicine and Tropical Health (2002), and International Congress of Infectious Diseases 2006), and member of several International and European Conferences on HIV, Infectious Diseases and Tropical Medicine. He is author and coauthor of more than 150 articles on peer reviewed biomedical journals with high impact factor. The current project constitutes a natural step forward in his professional (scientific, clinical and educational) path that has been evolving for over 40 years. Now, coordinating a multidisciplinary team with key players in the area of infectious diseases, Professor Antunes aims to make an important contribution to the understanding of the real situation of hepatitis B in Portugal.
Ler resumo completo ↓
Identificação

Identificação pessoal

Nome completo
Francisco José Nunes Antunes

Nomes de citação

  • Antunes, Francisco

Identificadores de autor

Ciência ID
0C14-AA72-045F
ORCID iD
0000-0001-7932-1154

Websites

Domínios de atuação

  • Ciências Médicas e da Saúde - Ciências da Saúde - Doenças Infeciosas

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Inglês Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1)
Formação
Grau Classificação
1989
Concluído
 Medicine (Título de Agregado)
Universidade de Lisboa Faculdade de Medicina, Portugal
 Aprovado por maioria
1985
Concluído
 Medicine (Doutoramento)
Universidade de Lisboa Faculdade de Medicina, Portugal
 Aprovada por Unanimidade, com distinção e louvor
1970
Concluído
 Medicine (Licenciatura)
Universidade de Lisboa Faculdade de Medicina, Portugal
 15 valores
Percurso profissional

Ciência

Categoria Profissional
Instituição de acolhimento 		Empregador
2013/07/24 - Atual Investigador Coordenador (carreira) (Investigação) Universidade de Lisboa Instituto de Saúde Ambiental, Portugal

Docência no Ensino Superior

Categoria Profissional
Instituição de acolhimento 		Empregador
2001/01/16 - 2006/01/15 Professor Catedrático (Docente Universitário) Universidade Nova de Lisboa Instituto de Higiene e Medicina Tropical, Portugal
1993/05/05 - 2003/05/04 Professor Associado (Docente Universitário) Universidade de Lisboa Faculdade de Medicina, Portugal
1985/03/19 - 1991/03/18 Professor Auxiliar (Docente Universitário) Universidade de Lisboa Faculdade de Medicina, Portugal

Outras Carreiras

Categoria Profissional
Instituição de acolhimento 		Empregador
1984 - 1990 Assistente (Técnico Superior de Saúde) Hospital de Santa Maria, Portugal

Cargos e Funções

Categoria Profissional
Instituição de acolhimento 		Empregador
1993/12/01 - 2013/08/30 Director de Unidade Orgânica Hospital de Santa Maria, Portugal
1992/09/01 - 2013/08/30 Director de Unidade Orgânica Universidade de Lisboa Faculdade de Medicina, Portugal
1998/01/01 - 2006/12/11 Director de Unidade Orgânica Universidade Nova de Lisboa Instituto de Higiene e Medicina Tropical, Portugal
Projetos

Bolsa

Designação Financiadores
2024 - 2025 Multi-country viral hepatitis COMunity Screening VAccination, and Care (VH-COMSAVAC)
VH-COMSAVAC
Principal investigator in Portugal
Em curso

Projeto

Designação Financiadores
2023 - 2024 Management program for people living with HIV (PLWH) [Programa de gestão de pessoas que vivem com VIH (PVVIH)]
NA
Coordinator
Em curso
2022 - 2024 Assessment of the impact of the new blister packaging of Biktarvy (BFTAF) on treatment compliance and satisfaction, in the treatment of people living with HIV
NA
Coordinator
Em curso
2022 - 2023 HIV infection - time between diagnosis and antiretroviral therapy initiation [Infeção por VIH - do diagnóstico ao início da terapêutica antirretrovírica em Portugal]
NA
Investigador responsável
Concluído
2019 - 2023 Hepatitis C virus infection micro-elimination approach in illicit substances users under follow-up in a drug addiction treatment unit in the Great Lisbon Area (Integrated Response Center from Setubal Peninsula)
NA
Investigador responsável
Em curso
2020 - 2021 Characterization of the continuum of health care provided to people infected with HIV, from diagnosis to the start of antiretroviral therapy, in Portugal [Caracterização do continuum dos cuidados médicos aos infectados por VIH, do diagnóstico ao início da terapêutica antirretrovírica, em Portugal]
NA
Investigador responsável
Em curso
2020 - 2021 Persistence of humoral immunity in patients with COVID-19 [Persistência da imunidade humoral em doentes com COVID-19]
NA
Co-Principal Investigator
2020 - 2021 Seroprevalence of SARS-CoV-2 among health care personnel in Portugal
NA
Co-Principal Investigator
2020 - 2021 Seroprevalence of SARS-CoV-2 in the population of the municipality of Vila Nova de Gaia, Portugal [Seroprevalência da SARS-CoV-2 na população do Concelho de Vila Nova de Gaia, Portugal]
NA
Co-Principal Investigator
2019 - 2021 Exploratory study for environmental research of Candida auris [Estudo exploratório para pesquisa ambiental de Candida auris ]
NA
Investigador responsável
Concluído
2017 - 2020 Hepatitis C - assessment of prevalence (and risk behaviors) in an environment of injecting drug use [Hepatite C - avaliação da prevalência (e dos comportamentos de risco) em ambiente de consumo injectado de drogas]
NA
Investigador responsável
Produções

Publicações

Artigo em conferência
  1. Álvaro de Carvalho; Ana Virgolino; José Germano de Sousa; Henrique Barros; Miguel Guimarães; Francisco Antunes. "Seroprevalence of SARS-CoV-2 among Health Care Personnel in Portugal". 2021.
    10.3390/ECERPH-3-09068
  2. Carvalho, Álvaro; Virgolino, Ana; Germano de Sousa, S; Barros, Henrique; Guimarães, Miguel; Antunes, Francisco. "Seroprevalence of SARS-CoV-2 among health care personnel in Portugal". Trabalho apresentado em The 3rd International Electronic Conference on Environmental Research and Public Health, 2021.
    No prelo
Artigo em revista
  1. Francisco Antunes; Ana Virgolino. "Monkeypox Mysteries of the New Outbreak in Non-Endemic Areas". International Journal of Environmental Research and Public Health (2022): https://doi.org/10.3390/ijerph192214881.
    10.3390/ijerph192214881
  2. Francisco Antunes; Rita Cordeiro; Ana Virgolino. "Monkeypox: From A Neglected Tropical Disease to a Public Health Threat". Infectious Disease Reports (2022): https://doi.org/10.3390/idr14050079.
    10.3390/idr14050079
  3. Vanessa Nicolau; Rui Cortes; Maria Lopes; Ana Virgolino; Osvaldo Santos; António Martins; Nancy Faria; et al. "HIV Infection: Time from Diagnosis to Initiation of Antiretroviral Therapy in Portugal, a Multicentric Study". Healthcare (2021): https://www.mdpi.com/2227-9032/9/7/797.
    10.3390/healthcare9070797
  4. Antunes, Francisco; Veríssimo, Cristina; Pereira, Álvaro Ayres; Sabino, Raquel. "Candida auris: Emergência Recente de um Fungo Patogénico Multirresistente". Acta Médica Portuguesa 33 10 (2020): 680. http://dx.doi.org/10.20344/amp.12419.
    10.20344/amp.12419
  5. Ana Virgolino; Francisco Antunes; Osvaldo Santos; Andreia Costa; Margarida Gaspar de Matos; Cristina Bárbara; Manuel Bicho; et al. "Towards a Global Perspective of Environmental Health: Defining the Research Grounds of an Institute of Environmental Health". Sustainability (2020): https://www.mdpi.com/2071-1050/12/21/8963.
    10.3390/su12218963
  6. Cátia Salamandane; Filipa Fonseca; Sónia Afonso; Maria Luisa Lobo; Francisco Antunes; Olga Matos. "Handling of Fresh Vegetables: Knowledge, Hygienic Behavior of Vendors, Public Health in Maputo Markets, Mozambique". International Journal of Environmental Research and Public Health (2020): https://www.mdpi.com/1660-4601/17/17/6302.
    10.3390/ijerph17176302
  7. Dickinson L; Gurjar R; Stöhr W; Bonora S; Owen A; D'Avolio A; Cursley A; et al. "Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trial.". The Journal of antimicrobial chemotherapy (2020): http://europepmc.org/abstract/med/31754703.
    10.1093/jac/dkz479
  8. Sabino R; Veríssimo C; Pereira ÁA; Antunes F. "Candida auris, an Agent of Hospital-Associated Outbreaks: Which Challenging Issues Do We Need to Have in Mind?". Microorganisms (2020): http://europepmc.org/abstract/med/32012865.
    10.3390/microorganisms8020181
  9. Carimo, A.A.; Gudo, E.S.; Maueia, C.; Mabunda, N.; Chambal, L.; Vubil, A.; Flora, A.; Antunes, F.; Bhatt, N.. "First report of occult hepatitis B infection among ART naïve HIV seropositive individuals in Maputo, Mozambique". PLoS ONE 13 1 (2018): http://www.scopus.com/inward/record.url?eid=2-s2.0-85040329375&partnerID=MN8TOARS.
    10.1371/journal.pone.0190775
  10. Chambal, L.M.; Samo Gudo, E.; Carimo, A.; Corte Real, R.; Mabunda, N.; Maueia, C.; Vubil, A.; et al. "HBV infection in untreated HIV-infected adults in Maputo, Mozambique". PLoS ONE 12 7 (2017): http://www.scopus.com/inward/record.url?eid=2-s2.0-85026412644&partnerID=MN8TOARS.
    10.1371/journal.pone.0181836
  11. Maltez, F.; Martins, T.; Póvoas, D.; Cabo, J.; Peres, H.; Antunes, F.; Perdigão, J.; Portugal, I.. "Multidrug-resistant tuberculosis by strains of beijing family, in patients from Lisbon, Portugal: Preliminary report,Tuberculose multirresistente por estirpes da família beijing, em doentes de Lisboa, Portugal: Estudo preliminar". Acta Medica Portuguesa 30 3 (2017): 175-184. http://www.scopus.com/inward/record.url?eid=2-s2.0-85016811868&partnerID=MN8TOARS.
    10.20344/amp.7882
  12. Duarte, H.; Cruz, J.P.; Aniceto, N.; Ribeiro, A.C.; Fernandes, A.; Paixão, P.; Antunes, F.; Morais, J.. "Population Approach to Efavirenz Therapy". Journal of Pharmaceutical Sciences 106 10 (2017): 3161-3166. http://www.scopus.com/inward/record.url?eid=2-s2.0-85026645839&partnerID=MN8TOARS.
    10.1016/j.xphs.2017.06.004
  13. Antunes, F.. "Atazanavir sulfate + cobicistat for the treatment of HIV infection". Expert Review of Anti-Infective Therapy 15 6 (2017): 569-576. http://www.scopus.com/inward/record.url?eid=2-s2.0-85019494414&partnerID=MN8TOARS.
    10.1080/14787210.2017.1323634
  14. Lambert-Niclot, S.; George, E.C.; Pozniak, A.; White, E.; Schwimmer, C.; Jessen, H.; Johnson, M.; et al. "Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: Raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART". Journal of Antimicrobial Chemotherapy 71 4 (2016): 1056-1062. http://www.scopus.com/inward/record.url?eid=2-s2.0-84964317330&partnerID=MN8TOARS.
    10.1093/jac/dkv427
  15. Esteves, F.; de Sousa, B.; Calderón, E.J.; Huang, L.; Badura, R.; Maltez, F.; Bassat, Q.; et al. "Multicentre study highlighting clinical relevance of new high-throughput methodologies in molecular epidemiology of Pneumocystis jirovecii pneumonia". Clinical Microbiology and Infection 22 6 (2016): 566.e9-566.e19. http://www.scopus.com/inward/record.url?eid=2-s2.0-84964878165&partnerID=MN8TOARS.
    10.1016/j.cmi.2016.03.013
  16. Winston, A.; Stöhr, W.; Antinori, A.; Arenas-Pinto, A.; Llibre, J.M.; Amieva, H.; Cabié, A.; et al. "Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy". HIV Medicine 17 6 (2016): 471-478. http://www.scopus.com/inward/record.url?eid=2-s2.0-84975246442&partnerID=MN8TOARS.
    10.1111/hiv.12344
  17. Mocroft A; Lundgren JD; Ross M; Law M; Reiss P; Kirk O; Smith C; et al. "Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.". (2015): http://europepmc.org/abstract/med/25826420.
    10.1371/journal.pmed.1001809
  18. De Santiago, I.; Miguel, J.P.; Antunes, F.. "Health communication: Preventing the spread of ebola virus disease in the Portuguese Spoken African Countries - Methodology KISS & KEYWORDS,Comunicação em saúde: Evitar o contágio da doença por vírus Ébola nos PALOP – Metodologia KISS & KEYWORDS". Acta Medica Portuguesa 28 2 (2015): 141-144. http://www.scopus.com/inward/record.url?eid=2-s2.0-84930457369&partnerID=MN8TOARS.
  19. Gallant, J.E.; Koenig, E.; Andrade-Villanueva, J.F.; Chetchotisakd, P.; DeJesus, E.; Antunes, F.; Arastéh, K.; et al. "Cobicistat Compared With Ritonavir as a Pharmacoenhancer for Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate: Week 144 Results". Journal of Acquired Immune Deficiency Syndromes 69 3 (2015): 338-340. http://www.scopus.com/inward/record.url?eid=2-s2.0-84933051378&partnerID=MN8TOARS.
    10.1097/QAI.0000000000000598
  20. Antunes, F.; Zindoga, P.; Gomes, P.; Augusto, O.; Mahumane, I.; Veloso, L.; Valadas, E.; Camacho, R.. "Development of nevirapine resistance in children exposed to the prevention of mother-to-child HIV-1 transmission programme in Maputo, Mozambique". PLoS ONE 10 7 (2015): http://www.scopus.com/inward/record.url?eid=2-s2.0-84941361103&partnerID=MN8TOARS.
    10.1371/journal.pone.0131994
  21. Esteves, F.; Calé, S.S.; Badura, R.; de Boer, M.G.; Maltez, F.; Calderón, E.J.; van der Reijden, T.J.; et al. "Diagnosis of Pneumocystis pneumonia: Evaluation of four serologic biomarkers". Clinical Microbiology and Infection 21 4 (2015): 379.e1-379.e10. http://www.scopus.com/inward/record.url?eid=2-s2.0-84928544137&partnerID=MN8TOARS.
    10.1016/j.cmi.2014.11.025
  22. Murray, D.D.; Suzuki, K.; Law, M.; Trebicka, J.; Neuhaus, J.; Wentworth, D.; Johnson, M.; et al. "Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: A case control study". PLoS ONE 10 10 (2015): http://www.scopus.com/inward/record.url?eid=2-s2.0-84949225661&partnerID=MN8TOARS.
    10.1371/journal.pone.0139981
  23. Petoumenos K; Reiss P; Ryom L; Rickenbach M; Sabin CA; El-Sadr W; d'Arminio Monforte A; et al. "Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations.". (2014): http://europepmc.org/abstract/med/24840675.
    10.1111/hiv.12162
  24. Shepherd L; Souberbielle JC; Bastard JP; Fellahi S; Capeau J; Reekie J; Reiss P; et al. "Prognostic value of vitamin D level for all-cause mortality, and association with inflammatory markers, in HIV-infected persons.". (2014): http://europepmc.org/abstract/med/24493824.
    10.1093/infdis/jiu074
  25. Mocroft A; Ryom L; Begovac J; Monforte AD; Vassilenko A; Gatell J; Florence E; et al. "Deteriorating renal function and clinical outcomes in HIV-positive persons.". (2014): http://europepmc.org/abstract/med/24983543.
    10.1097/QAD.0000000000000134
  26. Grint D; Peters L; Rockstroh JK; de Wit S; Mitsura VM; Knysz B; Pedersen C; et al. "Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosis.". (2014): http://europepmc.org/abstract/med/24468998.
    10.1097/QAD.0000000000000069
  27. Zoufaly A; Cozzi-Lepri A; Reekie J; Kirk O; Lundgren J; Reiss P; Jevtovic D; et al. "Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in Europe.". (2014): http://europepmc.org/abstract/med/24498036.
    10.1371/journal.pone.0087160
  28. Cavaco-Silva J; Abecasis A; Miranda AC; Poças J; Narciso J; Águas MJ; Maltez F; et al. "HIV-2 integrase polymorphisms and longitudinal genotypic analysis of HIV-2 infected patients failing a raltegravir-containing regimen.". (2014): http://europepmc.org/abstract/med/24681625.
    10.1371/journal.pone.0092747
  29. Borges, A.H.; Lundgren, J.D.; Ridolfo, A.; Katlama, C.; Antunes, F.; Grzeszczuk, A.; Blaxhult, A.; et al. "Thrombocytopenia is associated with an increased risk of cancer during treated HIV disease". AIDS 28 17 (2014): 2565-2571. http://www.scopus.com/inward/record.url?eid=2-s2.0-84927733996&partnerID=MN8TOARS.
    10.1097/QAD.0000000000000433
  30. Mocroft, A.; Reiss, P.; Rakhmanova, A.; Banhegyi, D.; Phillips, A.N.; De Wit, S.; Ristola, M.; et al. "A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe". Infection 42 4 (2014): 757-762. http://www.scopus.com/inward/record.url?eid=2-s2.0-84906791021&partnerID=MN8TOARS.
    10.1007/s15010-014-0630-4
  31. Esteves, F.; Aguiar, D.; Rosado, J.; Costa, M.L.; de Sousa, B.; Antunes, F.; Matos, O.. "Toxoplasma gondii prevalence in cats from Lisbon and in pigs from centre and south of Portugal". Veterinary Parasitology 200 1-2 (2014): 8-12. http://www.scopus.com/inward/record.url?eid=2-s2.0-84892857195&partnerID=MN8TOARS.
    10.1016/j.vetpar.2013.12.017
  32. Esteves, F.; Lee, C.-H.; de Sousa, B.; Badura, R.; Seringa, M.; Fernandes, C.; Gaspar, J.F.; Antunes, F.; Matos, O.. "(1-3)-Beta-D-glucan in association with lactate dehydrogenase as biomarkers of Pneumocystis pneumonia (PcP) in HIV-infected patients". European Journal of Clinical Microbiology and Infectious Diseases (2014): 1-8. http://www.scopus.com/inward/record.url?eid=2-s2.0-84893155966&partnerID=MN8TOARS.
    10.1007/s10096-014-2054-6
  33. Lobo ML; Augusto J; Antunes F; Ceita J; Xiao L; Codices V; Matos O. "Cryptosporidium spp., Giardia duodenalis, Enterocytozoon bieneusi and other intestinal parasites in young children in Lobata province, Democratic Republic of Sao Tome and Principe.". (2014): http://europepmc.org/abstract/med/24846205.
    10.1371/journal.pone.0097708
  34. Borges AH; O'Connor JL; Phillips AN; Baker JV; Vjecha MJ; Losso MH; Klinker H; et al. "Factors associated with D-dimer levels in HIV-infected individuals.". (2014): http://europepmc.org/abstract/med/24626096.
    10.1371/journal.pone.0090978
  35. Kamara DA; Ryom L; Ross M; Kirk O; Reiss P; Morlat P; Moranne O; et al. "Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D study.". (2014): http://europepmc.org/abstract/med/24666792.
    10.1186/1471-2369-15-51
  36. Sabin CA; Ryom L; De Wit S; Mocroft A; Phillips AN; Worm SW; Weber R; et al. "Associations between immune depression and cardiovascular events in HIV infection.". (2013): http://europepmc.org/abstract/med/23842128.
    10.1097/01.aids.0000432457.91228.f3
  37. Grint D; Peters L; Schwarze-Zander C; Beniowski M; Pradier C; Battegay M; Jevtovic D; et al. "Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA.". (2013): http://europepmc.org/abstract/med/23869664.
    10.1111/hiv.12068
  38. Grint D; Peters L; Reekie J; Soriano V; Kirk O; Knysz B; Suetnov O; et al. "Stability of hepatitis C virus (HCV) RNA levels among interferon-naive HIV/HCV-coinfected individuals treated with combination antiretroviral therapy.". (2013): http://europepmc.org/abstract/med/23534815.
    10.1111/hiv.12033
  39. Ryom L; Mocroft A; Kirk O; Worm SW; Kamara DA; Reiss P; Ross M; et al. "Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study.". (2013): http://europepmc.org/abstract/med/23382571.
    10.1093/infdis/jit043
  40. Vercauteren J; Theys K; Carvalho AP; Valadas E; Duque LM; Teófilo E; Faria T; et al. "The demise of multidrug-resistant HIV-1: the national time trend in Portugal.". (2013): http://europepmc.org/abstract/med/23228933.
    10.1093/jac/dks470
  41. Mocroft A; Phillips AN; Gatell J; Horban A; Ledergerber B; Zilmer K; Jevtovic D; et al. "CD4 cell count and viral load-specific rates of AIDS, non-AIDS and deaths according to current antiretroviral use.". (2013): http://europepmc.org/abstract/med/23698060.
    10.1097/QAD.0b013e32835cb766
  42. Cavaco-Silva J; Aleixo MJ; Van Laethem K; Faria D; Valadas E; Gonçalves Mde F; Gomes P; et al. "Mutations selected in HIV-2-infected patients failing a regimen including atazanavir.". (2013): http://europepmc.org/abstract/med/22977160.
    10.1093/jac/dks363
  43. Bjerk SM; Baker JV; Emery S; Neuhaus J; Angus B; Gordin FM; Pett SL; et al. "Biomarkers and bacterial pneumonia risk in patients with treated HIV infection: a case-control study.". (2013): http://europepmc.org/abstract/med/23457535.
    10.1371/journal.pone.0056249
  44. Gallant, J.E.; Koenig, E.; Andrade-Villanueva, J.; Chetchotisakd, P.; Dejesus, E.; Antunes, F.; Arastéh, K.; et al. "Cobicistat versus ritonavir as a pharmacoenhancer of atazanavir plus emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV type 1-infected patients: Week 48 results". Journal of Infectious Diseases 208 1 (2013): 32-39. http://www.scopus.com/inward/record.url?eid=2-s2.0-84878525908&partnerID=MN8TOARS.
    10.1093/infdis/jit122
  45. Peters, L.; Mocroft, A.; Soriano, V.; Rockstroh, J.; Rauch, A.; Karlsson, A.; Knysz, B.; et al. "Hyaluronic Acid Levels Predict Risk of Hepatic Encephalopathy and Liver-Related Death in HIV/Viral Hepatitis Coinfected Patients". PLoS ONE 8 5 (2013): http://www.scopus.com/inward/record.url?eid=2-s2.0-84878329914&partnerID=MN8TOARS.
    10.1371/journal.pone.0064283
  46. Lopes, J.A.; Melo, M.J.; Raimundo, M.; Fragoso, A.; Antunes, F.. "Long-term risk of mortality for acute kidney injury in HIV-infected patients: A cohort analysis". BMC Nephrology 14 1 (2013): http://www.scopus.com/inward/record.url?eid=2-s2.0-84873491077&partnerID=MN8TOARS.
    10.1186/1471-2369-14-32
  47. Theys, K.; Snoeck, J.; Vercauteren, J.; Abecasis, A.B.; Vandamme, A.-M.; Camacho, R.J.; Mansinho, K.; et al. "Decreasing population selection rates of resistance mutation K65R over time in HIV-1 patients receiving combination therapy including tenofovir". Journal of Antimicrobial Chemotherapy 68 2 (2013): 419-423. http://www.scopus.com/inward/record.url?eid=2-s2.0-84872396741&partnerID=MN8TOARS.
    10.1093/jac/dks380
  48. Valadas, E.; Gomes, A.; Sutre, A.; Brilha, S.; Wete, A.; Hänscheid, T.; Antunes, F.. "Tuberculosis with malaria or HIV co-infection in a large hospital in Luanda, Angola". Journal of Infection in Developing Countries 7 3 (2013): 269-272. http://www.scopus.com/inward/record.url?eid=2-s2.0-84875196099&partnerID=MN8TOARS.
    10.3855/jidc.2703
  49. Worm, S.W.; Bower, M.; Reiss, P.; Bonnet, F.; Law, M.; Fätkenheuer, G.; d'Arminio Monforte, A.; et al. "Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: A cohort study". BMC Infectious Diseases 13 1 (2013): http://www.scopus.com/inward/record.url?eid=2-s2.0-84885072530&partnerID=MN8TOARS.
    10.1186/1471-2334-13-471
  50. Perelman, J.; Alves, J.; Miranda, A.C.; Mateus, C.; Mansinho, K.; Antunes, F.; Oliveira, J.; et al. "Direct treatment costs of HIV/AIDS in Portugal". Revista de Saude Publica 47 5 (2013): 865-872. http://www.scopus.com/inward/record.url?eid=2-s2.0-84893181097&partnerID=MN8TOARS.
    10.1590/S0034-8910.2013047004598
  51. Lobo, M.L.; Esteves, F.; de Sousa, B.; Cardoso, F.; Cushion, M.T.; Antunes, F.; Matos, O.. "Therapeutic Potential of Caspofungin Combined with Trimethoprim-Sulfamethoxazole for Pneumocystis Pneumonia: A Pilot Study in Mice". PLoS ONE 8 8 (2013): http://www.scopus.com/inward/record.url?eid=2-s2.0-84881094365&partnerID=MN8TOARS.
    10.1371/journal.pone.0070619
  52. Esgalhado, R.; Esteves, F.; Antunes, F.; Matos, O.. "Study of the epidemiology of Pneumocystis carinii f. sp. suis in abattoir swine in Portugal". Medical Mycology 51 1 (2013): 66-71. http://www.scopus.com/inward/record.url?eid=2-s2.0-84870950720&partnerID=MN8TOARS.
    10.3109/13693786.2012.700123
  53. May MT; Hogg RS; Justice AC; Shepherd BE; Costagliola D; Ledergerber B; Thiébaut R; et al. "Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics.". (2012): http://europepmc.org/abstract/med/23148105.
    10.1093/ije/dys164
  54. Peters L; Grint D; Lundgren JD; Rockstroh JK; Soriano V; Reiss P; Grzeszczuk A; et al. "Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients.". (2012): http://europepmc.org/abstract/med/22781222.
    10.1097/QAD.0b013e3283574e71
  55. Molina JM; Lamarca A; Andrade-Villanueva J; Clotet B; Clumeck N; Liu YP; Zhong L; et al. "Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study.". (2012): http://europepmc.org/abstract/med/22015077.
    10.1016/S1473-3099(11)70249-3
  56. Kowalska JD; Reekie J; Mocroft A; Reiss P; Ledergerber B; Gatell J; d'Arminio Monforte A; et al. "Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapy.". (2012): http://europepmc.org/abstract/med/22112597.
    10.1097/QAD.0b013e32834e8805
  57. Borrego, P.; Calado, R.; Marcelino, J.M.; Bártolo, I.; Rocha, C.; Cavaco-Silva, P.; Doroana, M.; et al. "Baseline susceptibility of primary HIV-2 to entry inhibitors". Antiviral Therapy 17 3 (2012): 565-570. http://www.scopus.com/inward/record.url?eid=2-s2.0-84861694354&partnerID=MN8TOARS.
    10.3851/IMP1996
  58. Oliveira, V.; Bártolo, I.; Borrego, P.; Rocha, C.; Valadas, E.; Barreto, J.; Almeida, E.; Antunes, F.; Taveira, N.. "Genetic diversity and drug resistance profiles in HIV type 1- and HIV type 2-infected patients from Cape Verde Islands". AIDS Research and Human Retroviruses 28 5 (2012): 510-522. http://www.scopus.com/inward/record.url?eid=2-s2.0-84860482804&partnerID=MN8TOARS.
    10.1089/aid.2011.0174
  59. Carvalho, A.C.; Valadas, E.; França, L.; Carvalho, C.; Aleixo, M.J.; Mendez, J.; Marques, R.; et al. "Population mobility and the changing epidemics of HIV-2 in Portugal". HIV Medicine 13 4 (2012): 219-225. http://www.scopus.com/inward/record.url?eid=2-s2.0-84857993672&partnerID=MN8TOARS.
    10.1111/j.1468-1293.2011.00963.x
  60. Marcelino, J.M.; Borrego, P.; Nilsson, C.; Família, C.; Barroso, H.; Maltez, F.; Doroana, M.; et al. "Resistance to antibody neutralization in HIV-2 infection occurs in late stage disease and is associated with X4 tropism". AIDS 26 18 (2012): 2275-2284. http://www.scopus.com/inward/record.url?eid=2-s2.0-84870192423&partnerID=MN8TOARS.
    10.1097/QAD.0b013e328359a89d
  61. Antunes, F.. "Advances in antiretroviral therapy,Avanços na terapêutica anti-retrovírica". Acta Medica Portuguesa 25 3 (2012): 193-196. http://www.scopus.com/inward/record.url?eid=2-s2.0-84866950542&partnerID=MN8TOARS.
  62. Lobo, M.L.; Xiao, L.; Antunes, F.; Matos, O.. "Microsporidia as emerging pathogens and the implication for public health: A 10-year study on HIV-positive and -negative patients". International Journal for Parasitology 42 2 (2012): 197-205. http://www.scopus.com/inward/record.url?eid=2-s2.0-84856494158&partnerID=MN8TOARS.
    10.1016/j.ijpara.2011.12.002
  63. Antunes F. "[Advances in antiretroviral therapy].". (2012): http://europepmc.org/abstract/med/23069240.
  64. Reekie J; Kowalska JD; Karpov I; Rockstroh J; Karlsson A; Rakhmanova A; Horban A; et al. "Regional differences in AIDS and non-AIDS related mortality in HIV-positive individuals across Europe and Argentina: the EuroSIDA study.". (2012): http://europepmc.org/abstract/med/22911841.
    10.1371/journal.pone.0041673
  65. Petoumenos K; Worm SW; Fontas E; Weber R; De Wit S; Bruyand M; Reiss P; et al. "Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.". (2012): http://europepmc.org/abstract/med/23078769.
    10.7448/IAS.15.2.17426
  66. Mocroft A; Bannister WP; Kirk O; Kowalska JD; Reiss P; D'Arminio-Monforte A; Gatell J; et al. "The clinical benefits of antiretroviral therapy in severely immunocompromised HIV-1-infected patients with and without complete viral suppression.". (2012): http://europepmc.org/abstract/med/23013779.
    10.3851/IMP2407
  67. Markowitz N; Lopardo G; Wentworth D; Gey D; Babiker A; Fox L; Tavel J; STALWART Study Group. "Long-term effects of intermittent IL-2 in HIV infection: extended follow-up of the INSIGHT STALWART Study.". (2012): http://europepmc.org/abstract/med/23082173.
    10.1371/journal.pone.0047506
  68. Nelson, M.; Amaya, G.; Clumeck, N.; Arns da cunha, C.; Jayaweera, D.; Junod, P.; Li, T.; et al. "Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the phase III randomized, double-blind ECHO and THRIVE trials". Journal of Antimicrobial Chemotherapy 67 8 (2012): 2020-2028. http://www.scopus.com/inward/record.url?eid=2-s2.0-84864505008&partnerID=MN8TOARS.
    10.1093/jac/dks130
  69. Esteves, F.; Gaspar, J.; de Sousa, B.; Antunes, F.; Mansinho, K.; Matos, O.. "Pneumocystis jirovecii multilocus genotyping in pooled DNA samples: A new approach for clinical and epidemiological studies". Clinical Microbiology and Infection 18 6 (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-84860993899&partnerID=MN8TOARS.
    10.1111/j.1469-0691.2012.03828.x
  70. Eron JJ Jr; Rockstroh JK; Reynes J; Andrade-Villanueva J; Ramalho-Madruga JV; Bekker LG; Young B; et al. "Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial.". (2011): http://europepmc.org/abstract/med/21933752.
    10.1016/S1473-3099(11)70196-7
  71. Reekie J; Gatell JM; Yust I; Bakowska E; Rakhmanova A; Losso M; Krasnov M; et al. "Fatal and nonfatal AIDS and non-AIDS events in HIV-1-positive individuals with high CD4 cell counts according to viral load strata.". (2011): http://europepmc.org/abstract/med/21918422.
    10.1097/QAD.0b013e32834cdb4b
  72. Kruk A; Bannister W; Podlekareva DN; Chentsova NP; Rakhmanova AG; Horban A; Domingo P; et al. "Tuberculosis among HIV-positive patients across Europe: changes over time and risk factors.". (2011): http://europepmc.org/abstract/med/21610489.
    10.1097/QAD.0b013e328348fafd
  73. Viard JP; Souberbielle JC; Kirk O; Reekie J; Knysz B; Losso M; Gatell J; et al. "Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study.". (2011): http://europepmc.org/abstract/med/21522006.
    10.1097/QAD.0b013e328347f6f7
  74. Benard A; van Sighem A; Taieb A; Valadas E; Ruelle J; Soriano V; Calmy A; et al. "Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group.". (2011): http://europepmc.org/abstract/med/21507923.
    10.1093/cid/cir123
  75. Reekie J; Reiss P; Ledergerber B; Sedlacek D; Parczewski M; Gatell J; Katlama C; et al. "A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study.". (2011): http://europepmc.org/abstract/med/20812948.
    10.1111/j.1468-1293.2010.00877.x
  76. Bannister WP; Cozzi-Lepri A; Kjær J; Clotet B; Lazzarin A; Viard JP; Kronborg G; et al. "Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy.". (2011): http://europepmc.org/abstract/med/21393179.
    10.1093/jac/dkr006
  77. Pett SL; Carey C; Lin E; Wentworth D; Lazovski J; Miró JM; Gordin F; et al. "Predictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT).". (2011): http://europepmc.org/abstract/med/20812949.
    10.1111/j.1468-1293.2010.00875.x
  78. Paredes, R.; Puertas, M.C.; Bannister, W.; Kisic, M.; Cozzi-Lepri, A.; Pou, C.; Bellido, R.; et al. "A376s in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy". Journal of Infectious Diseases 204 5 (2011): 741-752. http://www.scopus.com/inward/record.url?eid=2-s2.0-80051742963&partnerID=MN8TOARS.
    10.1093/infdis/jir385
  79. Soriano, V.; Arastéh, K.; Migrone, H.; Lutz, T.; Opravil, M.; Andrade-Villanueva, J.; Antunes, F.; et al. "Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: The ARTEN Trial". Antiviral Therapy 16 3 (2011): 339-348. http://www.scopus.com/inward/record.url?eid=2-s2.0-79959435688&partnerID=MN8TOARS.
    10.3851/IMP1745
  80. Esteves, F.; Gaspar, J.; De Sousa, B.; Antunes, F.; Mansinho, K.; Matos, O.. "Clinical relevance of multiple single-nucleotide polymorphisms in Pneumocystis jirovecii pneumonia: Development of a multiplex PCR-single-base-extension methodology". Journal of Clinical Microbiology 49 5 (2011): 1810-1815. http://www.scopus.com/inward/record.url?eid=2-s2.0-79955526452&partnerID=MN8TOARS.
    10.1128/JCM.02303-10
  81. Hänscheid, T.; Badura, R.; Fernandes, M.L.; Antunes, F.; Cristino, J.M.. "The case of the disappearing mycobacteria in Ziehl-Neelsen-stained smears". International Journal of Infectious Diseases 15 4 (2011): http://www.scopus.com/inward/record.url?eid=2-s2.0-84855626148&partnerID=MN8TOARS.
    10.1016/j.ijid.2011.01.002
  82. Antunes, F.. "Antiretroviral therapy for naïve and for treatment-experienced HIV patients, and prevention of HIV transmission". Current Opinion in HIV and AIDS 6 SUPPL. 1 (2011): http://www.scopus.com/inward/record.url?eid=2-s2.0-83655196770&partnerID=MN8TOARS.
    10.1097/01.COH.0000410241.73270.df
  83. Lopes, J.A.; Melo, M.J.; Viegas, A.; Raimundo, M.; Câmara, I.; Antunes, F.; Da Costa, A.G.. "Acute kidney injury in hospitalized HIV-infected patients: A cohort analysis". Nephrology Dialysis Transplantation 26 12 (2011): 3888-3894. http://www.scopus.com/inward/record.url?eid=2-s2.0-82255185517&partnerID=MN8TOARS.
    10.1093/ndt/gfr192
  84. Soriano, V.; Grint, D.; D'Arminio Monforte, A.; Horban, A.; Leen, C.; Poveda, E.; Antunes, F.; et al. "Hepatitis delta in HIV-infected individuals in Europe". AIDS 25 16 (2011): 1987-1992. http://www.scopus.com/inward/record.url?eid=2-s2.0-80054975665&partnerID=MN8TOARS.
    10.1097/QAD.0b013e32834babb3
  85. Soares, R.S.; Tendeiro, R.; Foxall, R.B.; Baptista, A.P.; Cavaleiro, R.; Gomes, P.; Camacho, R.; et al. "Cell-associated viral burden provides evidence of ongoing viral replication in aviremic HIV-2-infected patients". Journal of Virology 85 5 (2011): 2429-2438. http://www.scopus.com/inward/record.url?eid=2-s2.0-79551712331&partnerID=MN8TOARS.
    10.1128/JVI.01921-10
  86. Kowalska JD; Mocroft A; Ledergerber B; Florence E; Ristola M; Begovac J; Sambatakou H; et al. "A standardized algorithm for determining the underlying cause of death in HIV infection as AIDS or non-AIDS related: results from the EuroSIDA study.". (2011): http://europepmc.org/abstract/med/21498154.
    10.1310/hct1202-109
  87. Trullas JC; Mocroft A; Cofan F; Tourret J; Moreno A; Bagnis CI; Fux CA; et al. "Dialysis and renal transplantation in HIV-infected patients: a European survey.". (2010): http://europepmc.org/abstract/med/20811290.
    10.1097/QAI.0b013e3181efbe59
  88. Friis-Møller N; Thiébaut R; Reiss P; Weber R; Monforte AD; De Wit S; El-Sadr W; et al. "Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study.". (2010): http://europepmc.org/abstract/med/20543702.
    10.1097/HJR.0b013e328336a150
  89. Mocroft A; Reiss P; Gasiorowski J; Ledergerber B; Kowalska J; Chiesi A; Gatell J; et al. "Serious fatal and nonfatal non-AIDS-defining illnesses in Europe.". (2010): http://europepmc.org/abstract/med/20700060.
    10.1097/QAI.0b013e3181e9be6b
  90. Reekie J; Mocroft A; Ledergerber B; Beniowski M; Clotet B; van Lunzen J; Chiesi A; et al. "History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change.". (2010): http://europepmc.org/abstract/med/20201975.
    10.1111/j.1468-1293.2009.00816.x
  91. Mocroft A; Kirk O; Reiss P; De Wit S; Sedlacek D; Beniowski M; Gatell J; et al. "Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients.". (2010): http://europepmc.org/abstract/med/20523203.
    10.1097/QAD.0b013e328339fe53
  92. Worm SW; Friis-Møller N; Bruyand M; D'Arminio Monforte A; Rickenbach M; Reiss P; El-Sadr W; et al. "High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome.". (2010): http://europepmc.org/abstract/med/19910787.
    10.1097/QAD.0b013e328334344e
  93. Eron JJ; Young B; Cooper DA; Youle M; Dejesus E; Andrade-Villanueva J; Workman C; et al. "Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials.". (2010): http://europepmc.org/abstract/med/20074791.
    10.1016/S0140-6736(09)62041-9
  94. Lopes, J.A.; Fernandes, P.; Jorge, S.; Resina, C.; Santos, C.; Pereira, Á.; Neves, J.; Antunes, F.; Gomes Da Costa, A.. "Long-term risk of mortality after acute kidney injury in patients with sepsis: A contemporary analysis". BMC Nephrology 11 1 (2010): http://www.scopus.com/inward/record.url?eid=2-s2.0-77952866158&partnerID=MN8TOARS.
    10.1186/1471-2369-11-9
  95. Esteves, F.; Gaspar, J.; Tavares, A.; Moser, I.; Antunes, F.; Mansinho, K.; Matos, O.. "Population structure of Pneumocystis jirovecii isolated from immunodeficiency virus-positive patients". Infection, Genetics and Evolution 10 2 (2010): 192-199. http://www.scopus.com/inward/record.url?eid=2-s2.0-76849107309&partnerID=MN8TOARS.
    10.1016/j.meegid.2009.12.007
  96. Tavel, J.A.; Babiker, A.; Carey, C.; Fisher, M.; Fox, L.; Gey, D.; Lopardo, G.D.; et al. "Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: The STALWART study". PLoS ONE 5 2 (2010): http://www.scopus.com/inward/record.url?eid=2-s2.0-77949618628&partnerID=MN8TOARS.
    10.1371/journal.pone.0009334
  97. Santos, N.C.; Martins E Silva, J.; Freitas, T.; Doroana, M.; Duarte, N.; Tavares, L.; Antunes, F.; Saldanha, C.. "Blood cell membrane fluidity and intracellular Ca2+ changes in antiretroviral-naïve and -treated HIV-1-infected patients". TheScientificWorldJournal 10 (2010): 350-355. http://www.scopus.com/inward/record.url?eid=2-s2.0-77749327970&partnerID=MN8TOARS.
    10.1100/tsw.2010.34
  98. Calado, M.; Matoso, P.; Santos-Costa, Q.; Espirito-Santo, M.; Machado, J.; Rosado, L.; Antunes, F.; et al. "Coreceptor usage by HIV-1 and HIV-2 primary isolates: The relevance of CCR8 chemokine receptor as an alternative coreceptor". Virology 408 2 (2010): 174-182. http://www.scopus.com/inward/record.url?eid=2-s2.0-78149410393&partnerID=MN8TOARS.
    10.1016/j.virol.2010.09.020
  99. Reekie, J.; Kosa, C.; Engsig, F.; Monforte, A.D.; Wiercinska-Drapalo, A.; Domingo, P.; Antunes, F.; et al. "Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies". Cancer 116 22 (2010): 5306-5315. http://www.scopus.com/inward/record.url?eid=2-s2.0-78449280149&partnerID=MN8TOARS.
    10.1002/cncr.25311
  100. Esteves, F.; Gaspar, J.; Marques, T.; Leite, R.; Antunes, F.; Mansinho, K.; Matos, O.. "Identification of relevant single-nucleotide polymorphisms in Pneumocystis jirovecii: Relationship with clinical data". Clinical Microbiology and Infection 16 7 (2010): 878-884. http://www.scopus.com/inward/record.url?eid=2-s2.0-77954634399&partnerID=MN8TOARS.
    10.1111/j.1469-0691.2009.03030.x
  101. Soriano, V.; Mocroft, A.; Peters, L.; Rockstroh, J.; Antunes, F.; Kirkby, N.; de Wit, S.; et al. "Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe". Journal of Antimicrobial Chemotherapy 65 3 (2010): 548-555. http://www.scopus.com/inward/record.url?eid=2-s2.0-77950329915&partnerID=MN8TOARS.
    10.1093/jac/dkp479
  102. Badura R; Antunes R; Janeiro N; Afonso C; Antunes F. "What drives a normal relation between T-CD4 and T-CD8?". (2010): http://europepmc.org/abstract/PMC/PMC3112930.
  103. Pereira A; Lopes da Cruz J; Carvalho C; Gonçalves C; Antunes F. "Comparative efficacy and safety of regimens including ritonavir-boosted lopinavir or nevirapine in antiretroviral-naive HIV-1-infected individuals.". (2010): http://europepmc.org/abstract/PMC/PMC3112884.
  104. Afonso C; Zagalo A; Janeiro N; Antunes F. "Genotype testing in HIV-infected pregnant women.". (2010): http://europepmc.org/abstract/PMC/PMC3112922.
  105. Katlama C; Haubrich R; Lalezari J; Lazzarin A; Madruga JV; Molina JM; Schechter M; et al. "Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials.". (2009): http://europepmc.org/abstract/med/19710593.
    10.1097/QAD.0b013e3283316a5e
  106. INSIGHT-ESPRIT Study Group; SILCAAT Scientific Committee; Abrams D; Lévy Y; Losso MH; Babiker A; Collins G; et al. "Interleukin-2 therapy in patients with HIV infection.". (2009): http://europepmc.org/abstract/med/19828532.
    10.1056/NEJMoa0903175
  107. Cozzi-Lepri A; Phillips AN; Martinez-Picado J; Monforte Ad; Katlama C; Eg Hansen AB; Horban A; et al. "Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings.". (2009): http://europepmc.org/abstract/med/19604043.
    10.1086/604731
  108. Rodger AJ; Fox Z; Lundgren JD; Kuller LH; Boesecke C; Gey D; Skoutelis A; et al. "Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection.". (2009): http://europepmc.org/abstract/med/19678756.
    10.1086/605447
  109. Kesselring AM; Wit FW; Sabin CA; Lundgren JD; Gill MJ; Gatell JM; Rauch A; et al. "Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy.". (2009): http://europepmc.org/abstract/med/19487907.
    10.1097/QAD.0b013e32832d3b54
  110. Sension M; Andrade Neto JL; Grinsztejn B; Molina JM; Zavala I; González-García J; Donnelly A; et al. "Improvement in lipid profiles in antiretroviral-experienced HIV-positive patients with hyperlipidemia after a switch to unboosted atazanavir.". (2009): http://europepmc.org/abstract/med/19346966.
    10.1097/QAI.0b013e3181a5701c
  111. Peters L; Mocroft A; Soriano V; Rockstroh JK; Losso M; Valerio L; Aldins P; et al. "Hepatitis C virus coinfection does not influence the CD4 cell recovery in HIV-1-infected patients with maximum virologic suppression.". (2009): http://europepmc.org/abstract/med/19360931.
    10.1097/QAI.0b013e318198a0e1
  112. Antiretroviral Therapy Cohort Collaboration (ART-CC); Mocroft A; Sterne JA; Egger M; May M; Grabar S; Furrer H; et al. "Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal.". (2009): http://europepmc.org/abstract/med/19275498.
    10.1086/597468
  113. Mocroft A; Wyatt C; Szczech L; Neuhaus J; El-Sadr W; Tracy R; Kuller L; et al. "Interruption of antiretroviral therapy is associated with increased plasma cystatin C.". (2009): http://europepmc.org/abstract/med/19050388.
    10.1097/QAD.0b013e32831cc129
  114. Esteves, F.; Tavares, A.; Costa, M.C.; Gaspar, J.; Antunes, F.; Matos, O.. "Genetic characterization of the UCS and Kex1 loci of Pneumocystis jirovecii". European Journal of Clinical Microbiology and Infectious Diseases 28 2 (2009): 175-178. http://www.scopus.com/inward/record.url?eid=2-s2.0-59449108829&partnerID=MN8TOARS.
    10.1007/s10096-008-0596-1
  115. Lobo, M.L.; Xiao, L.; Antunes, F.; Matos, O.. "Occurrence of Cryptosporidium and Giardia genotypes and subtypes in raw and treated water in Portugal". Letters in Applied Microbiology 48 6 (2009): 732-737. http://www.scopus.com/inward/record.url?eid=2-s2.0-65649088716&partnerID=MN8TOARS.
    10.1111/j.1472-765X.2009.02605.x
  116. Valadas, E.; França, L.; Sousa, S.; Antunes, F.. "20 years of HIV-2 infection in portugal: Trends and changes in epidemiology". Clinical Infectious Diseases 48 8 (2009): 1166-1167. http://www.scopus.com/inward/record.url?eid=2-s2.0-63649103888&partnerID=MN8TOARS.
    10.1086/597504
  117. Lopes, J.A.; Jorge, S.; Resina, C.; Santos, C.; Pereira, A.; Neves, J.; Antunes, F.; Prata, M.M.. "Acute kidney injury in patients with sepsis: a contemporary analysis". International Journal of Infectious Diseases 13 2 (2009): 176-181. http://www.scopus.com/inward/record.url?eid=2-s2.0-60849083523&partnerID=MN8TOARS.
    10.1016/j.ijid.2008.05.1231
  118. Descamps D; Chazallon C; Loveday C; Bacheler L; Goodall R; Yéni P; Cooper DA; et al. "Resistance and virological response analyses in a three initial treatment strategy trial: a substudy of the INITIO trial.". (2009): http://europepmc.org/abstract/med/20133269.
    10.1310/hct1006-385
  119. Fox Z; Phillips A; Cohen C; Neuhaus J; Baxter J; Emery S; Hirschel B; et al. "Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen.". (2008): http://europepmc.org/abstract/med/18981767.
    10.1097/QAD.0b013e328311d16f
  120. Antiretroviral Therapy Cohort Collaboration (ART-CC); Mugavero MJ; May M; Harris R; Saag MS; Costagliola D; Egger M; et al. "Does short-term virologic failure translate to clinical events in antiretroviral-naive patients initiating antiretroviral therapy in clinical practice?". (2008): http://europepmc.org/abstract/med/19005271.
    10.1097/QAD.0b013e328318f130
  121. Reekie J; Mocroft A; Sambatakou H; Machala L; Chiesi A; van Lunzen J; Clumeck N; et al. "Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?". (2008): http://europepmc.org/abstract/med/18981778.
    10.1097/QAD.0b013e328317a6eb
  122. Soriano V; Mocroft A; Rockstroh J; Ledergerber B; Knysz B; Chaplinskas S; Peters L; et al. "Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe.". (2008): http://europepmc.org/abstract/med/18767985.
    10.1086/592171
  123. D'Arminio Monforte, A.; Abrams, D.; Pradier, C.; Weber, R.; Reiss, P.; Bonnet, F.; Kirk, O.; et al. "HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies". AIDS 22 16 (2008): 2143-2153. http://www.scopus.com/inward/record.url?eid=2-s2.0-55249101754&partnerID=MN8TOARS.
    10.1097/QAD.0b013e3283112b77
  124. Marcelino, J.M.; Nilsson, C.; Barroso, H.; Gomes, P.; Borrego, P.; Maltez, F.; Rosado, L.; et al. "Envelope-specific antibody response in HIV-2 infection: C2V3C3-specific IgG response is associated with disease progression". AIDS 22 17 (2008): 2257-2265. http://www.scopus.com/inward/record.url?eid=2-s2.0-56549116048&partnerID=MN8TOARS.
    10.1097/QAD.0b013e3283155546
  125. Borrego, P.; Marcelino, J.M.; Rocha, C.; Doroana, M.; Antunes, F.; Maltez, F.; Gomes, P.; et al. "The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients". Retrovirology 5 (2008): http://www.scopus.com/inward/record.url?eid=2-s2.0-53549101005&partnerID=MN8TOARS.
    10.1186/1742-4690-5-78
  126. Esteves, F.; Montes-cano, M.A.; De La Horra, C.; Costa, M.C.; Calderón, E.J.; Antunes, F.; Matos, O.. "Pneumocystis jirovecii multilocus genotyping profiles in patients from Portugal and Spain". Clinical Microbiology and Infection 14 4 (2008): 356-362. http://www.scopus.com/inward/record.url?eid=2-s2.0-40549145169&partnerID=MN8TOARS.
    10.1111/j.1469-0691.2007.01944.x
  127. Emery, S.; Neuhaus, J.A.; Phillips, A.N.; Babiker, A.; Cohen, C.J.; Gatell, J.M.; Girard, P.-M.; et al. "Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART Study". Journal of Infectious Diseases 197 8 (2008): 1133-1144. http://www.scopus.com/inward/record.url?eid=2-s2.0-42549121220&partnerID=MN8TOARS.
    10.1086/586713
  128. Garrido, C.; Zahonero, N.; Fernándes, D.; Serrano, D.; Silva, A.R.; Ferraria, N.; Antúnes, F.; et al. "Subtype variability, virological response and drug resistance assessed on dried blood spots collected from HIV patients on antiretroviral therapy in Angola". Journal of Antimicrobial Chemotherapy 61 3 (2008): 694-698. http://www.scopus.com/inward/record.url?eid=2-s2.0-40049096325&partnerID=MN8TOARS.
    10.1093/jac/dkm515
  129. Calmy, A.; Carey, D.; Mallon, P.W.G.; Wand, H.; Law, M.; Cooper, D.A.; Carr, A.; et al. "Early changes in adipokine levels and baseline limb fat may predict HIV lipoatrophy over 2 years following initiation of antiretroviral therapy". HIV Medicine 9 2 (2008): 101-110. http://www.scopus.com/inward/record.url?eid=2-s2.0-38949120915&partnerID=MN8TOARS.
    10.1111/j.1468-1293.2007.00527.x
  130. Bannister, W.P.; Ruiz, L.; Cozzi-Lepri, A.; Mocroft, A.; Kirk, O.; Staszewski, S.; Loveday, C.; et al. "Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA". AIDS 22 3 (2008): 367-376. http://www.scopus.com/inward/record.url?eid=2-s2.0-38149112713&partnerID=MN8TOARS.
    10.1097/QAD.0b013e3282f3cc35
  131. Mocroft, A.; Horban, A.; Clotet, B.; D'Arminio Monforte, A.; Bogner, J.R.; Aldins, P.; Staub, T.; et al. "Regional differences in the risk of triple class failure in European patients starting combination antiretroviral therapy after 1 January 1999". HIV Medicine 9 1 (2008): 41-46. http://www.scopus.com/inward/record.url?eid=2-s2.0-38349075733&partnerID=MN8TOARS.
    10.1111/j.1468-1293.2008.00519.x
  132. Lundgren, J.D.; Babiker, A.; El-Sadr, W.; Emery, S.; Grund, B.; Neaton, J.D.; Neuhaus, J.; et al. "Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: Role of CD4+ cell counts and HIV RNA levels during follow-up". Journal of Infectious Diseases 197 8 (2008): 1145-1155. http://www.scopus.com/inward/record.url?eid=2-s2.0-42549131481&partnerID=MN8TOARS.
    10.1086/529523
  133. El-Sadr, W.M.; Grund, B.; Neaton, J.D.; Neuhaus, J.; Cohen, C.J.; Darbyshire, J.; Babiker, A.; et al. "Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: A randomized trial". Annals of Internal Medicine 149 5 (2008): 289-299. http://www.scopus.com/inward/record.url?eid=2-s2.0-51049084622&partnerID=MN8TOARS.
    10.7326/0003-4819-149-5-200809020-00003
  134. Albuquerque, A.S.; Foxall, R.B.; Cortesão, C.S.; Soares, R.S.; Doroana, M.; Ribeiro, A.; Lucas, M.; et al. "Low CD4 T-cell counts despite low levels of circulating HIV: Insights from the comparison of HIV-1 infected patients with a discordant response to antiretroviral therapy to patients with untreated advanced HIV-2 disease". Clinical Immunology 125 1 (2007): 67-75. http://www.scopus.com/inward/record.url?eid=2-s2.0-34548488232&partnerID=MN8TOARS.
    10.1016/j.clim.2007.07.001
  135. Gatell, J.; Salmon-Ceron, D.; Lazzarin, A.; Van Wijngaerden, E.; Antunes, F.; Leen, C.; Horban, A.; et al. "Efficacy and safety of atazanavir-based highly active antiretroviral therapy in patients with virologic suppression switched from a stable, boosted or unboosted protease inhibitor treatment regimen: The SWAN study (AI424-097) 48-week results". Clinical Infectious Diseases 44 11 (2007): 1484-1492. http://www.scopus.com/inward/record.url?eid=2-s2.0-34249078589&partnerID=MN8TOARS.
    10.1086/517497
  136. Lopes, J.A.; Jorge, S.; Resina, C.; Santos, C.; Pereira, Á.; Neves, J.; Antunes, F.; Prata, M.M.. "Acute renal failure in patients with sepsis". Critical Care 11 (2007): http://www.scopus.com/inward/record.url?eid=2-s2.0-39549084929&partnerID=MN8TOARS.
    10.1186/cc5735
  137. Lopes, J.A.; Jorge, S.; Resina, C.; Santos, C.; Pereira, Á.; Neves, J.; Antunes, F.; Prata, M.M.. "Prognostic utility of RIFLE for acute renal failure in patients with sepsis". Critical Care 11 (2007): http://www.scopus.com/inward/record.url?eid=2-s2.0-39549104501&partnerID=MN8TOARS.
    10.1186/cc5722
  138. Fox, Z.; Antunes, F.; Davey, R.; Gazzard, B.; Klimas, N.; Labriola, A.; Losso, M.; et al. "Predictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count = 300 cells/µL who were assigned to 7.5 MIU interleukin-2". HIV Medicine 8 2 (2007): 112-123. http://www.scopus.com/inward/record.url?eid=2-s2.0-33847773493&partnerID=MN8TOARS.
    10.1111/j.1468-1293.2007.00440.x
  139. Cozzi-Lepri, A.; Phillips, A.N.; Ruiz, L.; Clotet, B.; Loveday, C.; Kjaer, J.; Mens, H.; et al. "Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen". AIDS 21 6 (2007): 721-732. http://www.scopus.com/inward/record.url?eid=2-s2.0-34147138794&partnerID=MN8TOARS.
    10.1097/QAD.0b013e3280141fdf
  140. Lopes, J.A.; Fernandes, J.; Jorge, S.; Neves, J.; Antunes, F.; Prata, M.M.. "Acute renal failure in critically ill HIV-infected patients". Critical Care 11 (2007): http://www.scopus.com/inward/record.url?eid=2-s2.0-34248163909&partnerID=MN8TOARS.
    10.1186/cc5141
  141. Lopes, J.A.; Fernandes, J.; Jorge, S.; Neves, J.; Antunes, F.; Prata, M.M.. "An assessment of the RIFLE criteria for acute renal failure in critically ill HIV-infected patients". Critical Care 11 (2007): http://www.scopus.com/inward/record.url?eid=2-s2.0-34248171835&partnerID=MN8TOARS.
    10.1186/cc5121
  142. Sterne, J.A.C.; May, M.; Sabin, C.; Phillips, A.; Costagliola, D.; Chêne, G.; Justice, A.C.; et al. "Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients". Journal of Acquired Immune Deficiency Syndromes 46 5 (2007): 607-615. http://www.scopus.com/inward/record.url?eid=2-s2.0-36549004647&partnerID=MN8TOARS.
    10.1097/QAI.0b013e31815b7dba
  143. Collins, S.; Mertenskoetter, T.; Loeliger, E.; Tressler, R.; Weller, I.; Friis-Møller, N.; Worm, S.W.; et al. "Liver-related deaths in persons infected with the human immunodeficiency virus: The D:A:D Study". Archives of Internal Medicine 166 15 (2006): 1632-1641. http://www.scopus.com/inward/record.url?eid=2-s2.0-85062055676&partnerID=MN8TOARS.
    10.1001/archinte.166.15.1632
  144. Costa, M.C.; Esteves, F.; Antunes, F.; Matos, O.. "Genetic characterization of the dihydrofolate reductase gene of Pneumocystis jirovecii isolates from Portugal". Journal of Antimicrobial Chemotherapy 58 6 (2006): 1246-1249. http://www.scopus.com/inward/record.url?eid=2-s2.0-33845349672&partnerID=MN8TOARS.
    10.1093/jac/dkl411
  145. Cahn, P.; Villacian, J.; Lazzarin, A.; Katlama, C.; Grinsztejn, B.; Arasteh, K.; López, P.; et al. "Ritonavir-boosted tipranavir demonstrates superior efficacy to ritonavir-boosted protease inhibitors in treatment-experienced HIV-infected patients: 24-Week results of the RESIST-2 trial". Clinical Infectious Diseases 43 10 (2006): 1347-1356. http://www.scopus.com/inward/record.url?eid=2-s2.0-33750687934&partnerID=MN8TOARS.
    10.1086/508352
  146. Alves, M.; Ribeiro, A.M.; Neto, C.; Ferreira, E.; Benoliel, M.J.; Antunes, F.; Matos, O.. "Distribution of Cryptosporidium species and subtypes in water samples in Portugal: A preliminary study". Journal of Eukaryotic Microbiology 53 SUPPL. 1 (2006): http://www.scopus.com/inward/record.url?eid=2-s2.0-33751354781&partnerID=MN8TOARS.
    10.1111/j.1550-7408.2006.00162.x
  147. Mocroft, A.; Horban, A.; Clumeck, N.; Stellbrink, H.J.; d'Arminio Monforte, A.; Zilmer, K.; Kirk, O.; et al. "Comparison of single and boosted protease inhibitor versus nonnucleoside reverse transcriptase inhibitor-containing cART regimens in antiretroviral-naïve patients starting cART after January 1, 2000". HIV Clinical Trials 7 6 (2006): 271-284. http://www.scopus.com/inward/record.url?eid=2-s2.0-33846531821&partnerID=MN8TOARS.
    10.1310/H657-L775-83J5-8654
  148. Alves, M.; Xiao, L.; Antunes, F.; Matos, O.. "Distribution of Cryptosporidium subtypes in humans and domestic and wild ruminants in Portugal". Parasitology Research 99 3 (2006): 287-292. http://www.scopus.com/inward/record.url?eid=2-s2.0-33745741781&partnerID=MN8TOARS.
    10.1007/s00436-006-0164-5
  149. Mocroft, A.; Neaton, J.; Bebchuk, J.; Staszewski, S.; Antunes, F.; Knysz, B.; Law, M.; Phillips, A.N.; Lundgren, J.D.. "The feasibility of clinical endpoint trials in HIV infection in the highly active antiretroviral treatment (HAART) era". Clinical Trials 3 2 (2006): 119-132. http://www.scopus.com/inward/record.url?eid=2-s2.0-33744796788&partnerID=MN8TOARS.
    10.1191/1740774506cn138oa
  150. Mocroft, A.; Phillips, A.N.; Ledergerber, B.; Katlama, C.; Chiesi, A.; Goebel, F.-D.; Knysz, B.; et al. "Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremia". AIDS 20 8 (2006): 1141-1150. http://www.scopus.com/inward/record.url?eid=2-s2.0-33646881763&partnerID=MN8TOARS.
    10.1097/01.aids.0000226954.95094.39
  151. Matos, O.; Costa, M.C.; Correia, I.; Monteiro, P.; Roldão Vieira, J.; Soares, J.; Bonnet, M.; Esteves, F.; Antunes, F.. "Pneumocystis jiroveci infection in immunocompetent patients with pulmonary disorders, in Portugal,Infecção por Pneumocystis jiroveci: Em imunocompetentes com patologia pulmonar, em Portugal". Acta Medica Portuguesa 19 2 (2006): 121-126. http://www.scopus.com/inward/record.url?eid=2-s2.0-33750217846&partnerID=MN8TOARS.
  152. Lobo, M.L.; Xiao, L.; Cama, V.; Stevens, T.; Antunes, F.; Matos, O.. "Genotypes of Enterocytozoon bieneusi in mammals in Portugal". Journal of Eukaryotic Microbiology 53 SUPPL. 1 (2006): http://www.scopus.com/inward/record.url?eid=2-s2.0-33751376604&partnerID=MN8TOARS.
    10.1111/j.1550-7408.2006.00174.x
  153. Costa, M.C.; Esteves, F.; Antunes, F.; Matos, O.. "Multilocus genotyping of Pneumocystis jirovecii in immunocompromised patients: Preliminary results". Journal of Eukaryotic Microbiology 53 SUPPL. 1 (2006): http://www.scopus.com/inward/record.url?eid=2-s2.0-33751368194&partnerID=MN8TOARS.
    10.1111/j.1550-7408.2006.00190.x
  154. Lobo, M.L.; Xiao, L.; Cama, V.; Magalhães, N.; Antunes, F.; Matos, O.. "Identification of potentially human-pathogenic Enterocytozoon bieneusi genotypes in various birds". Applied and Environmental Microbiology 72 11 (2006): 7380-7382. http://www.scopus.com/inward/record.url?eid=2-s2.0-33750994348&partnerID=MN8TOARS.
    10.1128/AEM.01394-06
  155. Martins-Silva, J.; Santos, N.C.; Doroana, M.; Duarte, N.; Tavares, L.; Antunes, F.; Saldanha, C.. "Changes in blood cell membrane properties in HIV type-1-infected patients". AIDS Research and Human Retroviruses 22 9 (2006): 849-853. http://www.scopus.com/inward/record.url?eid=2-s2.0-33751026185&partnerID=MN8TOARS.
    10.1089/aid.2006.22.849
  156. Valadas, E.; Antunes, F.; Ribeiro, C.. "Is there a gender shift in HCV infection? [3]". International Journal of Infectious Diseases 9 4 (2005): 230-231. http://www.scopus.com/inward/record.url?eid=2-s2.0-20444433228&partnerID=MN8TOARS.
    10.1016/j.ijid.2004.07.011
  157. Konopnicki, D.; Mocroft, A.; De Wit, S.; Antunes, F.; Ledergerber, B.; Katlama, C.; Zilmer, K.; et al. "Hepatitis B and HIV: Prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort". AIDS 19 6 (2005): 593-601. http://www.scopus.com/inward/record.url?eid=2-s2.0-20244373332&partnerID=MN8TOARS.
  158. Lemos, V.; Graczyk, T.K.; Alves, M.; Lobo, M.L.; Sousa, M.C.; Antunes, F.; Matos, O.. "Identification and determination of the viability of Giardia lamblia cysts and Cryptosporidium parvum and Cryptosporidium hominis oocysts in human fecal and water supply samples by fluorescent in situ hybridization (FISH) and monoclonal antibodies". Parasitology Research 98 1 (2005): 48-53. http://www.scopus.com/inward/record.url?eid=2-s2.0-27944449613&partnerID=MN8TOARS.
    10.1007/s00436-005-0018-6
  159. Costa, M.C.; Gaspar, J.; Mansinho, K.; Esteves, F.; Antunes, F.; Matos, O.. "Detection of pneumocystis jirovecii dihydropteroate synthase polymorphisms in patients with Pneumocystis pneumonia". Scandinavian Journal of Infectious Diseases 37 10 (2005): 766-771. http://www.scopus.com/inward/record.url?eid=2-s2.0-27744556319&partnerID=MN8TOARS.
    10.1080/00365540510038505
  160. Alves, M.; Xiao, L.; Lemos, V.; Zhou, L.; Cama, V.; Da Cunha, M.B.; Matos, O.; Antunes, F.. "Occurrence and molecular characterization of Cryptosporidium spp. in mammals and reptiles at the Lisbon Zoo". Parasitology Research 97 2 (2005): 108-112. http://www.scopus.com/inward/record.url?eid=2-s2.0-24044457975&partnerID=MN8TOARS.
    10.1007/s00436-005-1384-9
  161. Valadas, E.; Antunes, F.. "Tuberculosis, a re-emergent disease". European Journal of Radiology 55 2 (2005): 154-157. http://www.scopus.com/inward/record.url?eid=2-s2.0-22144450297&partnerID=MN8TOARS.
    10.1016/j.ejrad.2005.04.013
  162. Tillmann, H.L.; Kaiser, T.; Fox, Z.; Staszewski, S.; Antunes, F.; Monforte, A.D.; Vernazza, P.; et al. "Impact of coinfection with HIV-1 and GB Virus C in patients receiving a ritonavir-boosted HAART regimen: A substudy to the MaxCmin1 trial [2]". Journal of Acquired Immune Deficiency Syndromes 40 3 (2005): 378-380. http://www.scopus.com/inward/record.url?eid=2-s2.0-27444442546&partnerID=MN8TOARS.
    10.1097/01.qai.0000180079.60945.a3
  163. Constant, C.A.; Ferreira, P.B.; Valadas, E.; Antunes, F.. "Multi-drug-resistant tuberculosis in a Department of Infectious Diseases,Tuberculose multirresistente". Acta Medica Portuguesa 17 2 (2004): 157-166. http://www.scopus.com/inward/record.url?eid=2-s2.0-9644258523&partnerID=MN8TOARS.
  164. Matos, O.; Alves, M.; Xiao, L.; Cama, V.; Antunes, F.. "Cryptosporidium felis and C. meleagridis in persons with HIV, Portugal [1]". Emerging Infectious Diseases 10 12 (2004): 2256-2257. http://www.scopus.com/inward/record.url?eid=2-s2.0-9744260960&partnerID=MN8TOARS.
  165. Valadas, E.; Hänscheid, T.; Antunes, F.. "HIV infection and non-tuberculous mycobacteria: How important in southern European countries?". Scandinavian Journal of Infectious Diseases 36 9 (2004): 685-686. http://www.scopus.com/inward/record.url?eid=2-s2.0-4644299011&partnerID=MN8TOARS.
    10.1080/00365540410020811
  166. Antunes, F.. "Central nervous system AIDS - Related diseases". Acta Neurochirurgica 146 10 (2004): 1071-1074. http://www.scopus.com/inward/record.url?eid=2-s2.0-6344254277&partnerID=MN8TOARS.
    10.1007/s00701-004-0334-0
  167. Ledergerber, B.; Lundgren, J.D.; Sarah Walker, A.; Sabin, C.; Justice, A.; Reiss, P.; Mussini, C.; et al. "Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes". Lancet 364 9428 (2004): 51-62. http://www.scopus.com/inward/record.url?eid=2-s2.0-3042740596&partnerID=MN8TOARS.
    10.1016/S0140-6736(04)16589-6
  168. Mocroft, A.; Kirk, O.; Clumeck, N.; Gargalianos-Kakolyris, P.; Trocha, H.; Chentsova, N.; Antunes, F.; et al. "The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: The EuroSIDA study". Cancer 100 12 (2004): 2644-2654. http://www.scopus.com/inward/record.url?eid=2-s2.0-2642570047&partnerID=MN8TOARS.
    10.1002/cncr.20309
  169. Civljak, R.; Begovac, J.; Puro, V.; Cicalini, S.; De Carli, G.; Ippolito, G.; Balslev, U.; et al. "European recommendations for post-exposure prophylaxis of HIV-infection in health care workers - Croatian guidelines,Europske preporuke za postekspozicijsku profilaksu HIV-infekcije u zdravstvenih djelatnika - Hrvatske smjernice". Infektoloski Glasnik 24 3 (2004): 139-144. http://www.scopus.com/inward/record.url?eid=2-s2.0-17844396021&partnerID=MN8TOARS.
  170. Matos, O.; Lobo, M.L.; Teles, A.; Antunes, F.. "Is microspiridial infection in animals a potential source for human microsporidiosis?". Southeast Asian Journal of Tropical Medicine and Public Health 35 SUPPL. 1 (2004): 48-53. http://www.scopus.com/inward/record.url?eid=2-s2.0-33750988919&partnerID=MN8TOARS.
  171. Valadas, E.; Antunes, F.; Kanki, P.; Mullins, C.. "HIV-2: The Portuguese connection [7] (multiple letters)". Clinical Infectious Diseases 39 10 (2004): 1553-1554. http://www.scopus.com/inward/record.url?eid=2-s2.0-8744237304&partnerID=MN8TOARS.
    10.1086/425506
  172. Mocroft, A.; d'Arminio Monforte, A.; Kirk, O.; Johnson, M.A.; Friis-Moller, N.; Banhegyi, D.; Blaxhult, A.; et al. "Changes in hospital admissions across Europe: 1995-2003. Results from the EuroSIDA study". HIV Medicine 5 6 (2004): 437-447. http://www.scopus.com/inward/record.url?eid=2-s2.0-9244257277&partnerID=MN8TOARS.
    10.1111/j.1468-1293.2004.00250.x
  173. Puro, V.; Cicalini, S.; De Carli, G.; Soldani, F.; Antunes, F.; Balslev, U.; Begovac, J.; et al. "Post-exposure prophylaxis of HIV infection in healthcare workers: Recommendations for the European setting". European Journal of Epidemiology 19 6 (2004): 577-584. http://www.scopus.com/inward/record.url?eid=2-s2.0-3442886200&partnerID=MN8TOARS.
    10.1023/B:EJEP.0000032349.57057.8a
  174. López-Vélez, R.; Videla, S.; Márquez, M.; Boix, V.; Jiménez-Mejías, M.E.; Górgolas, M.; Arribas, J.R.; et al. "Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients". Journal of Antimicrobial Chemotherapy 53 3 (2004): 540-543. http://www.scopus.com/inward/record.url?eid=2-s2.0-12144285962&partnerID=MN8TOARS.
    10.1093/jac/dkh084
  175. D'Arminio Monforte, A.; Cinque, P.; Mocroft, A.; Goebel, F.-D.; Antunes, F.; Katlama, C.; Justesen, U.S.; et al. "Changing Incidence of Central Nervous System Diseases in the EuroSIDA Cohort". Annals of Neurology 55 3 (2004): 320-328. http://www.scopus.com/inward/record.url?eid=2-s2.0-10744220788&partnerID=MN8TOARS.
    10.1002/ana.10827
  176. Antunes, F.; Walker, M.; Moyle, G.J.. "Efficacy and Tolerability of Zalcitabine Twice Daily (HIVBID Study) [2]". Journal of Acquired Immune Deficiency Syndromes 35 2 (2004): 205-206. http://www.scopus.com/inward/record.url?eid=2-s2.0-1642540111&partnerID=MN8TOARS.
    10.1097/00126334-200402010-00017
  177. Delgado, E.; Fonseca, I.P.; Fazendeiro, I.; Matos, O.; Antunes, F.; Cunha, M.B.. "Cryptosporidium spp. in ruminants at the Lisbon Zoo". Journal of Zoo and Wildlife Medicine 34 4 (2003): 352-356. http://www.scopus.com/inward/record.url?eid=2-s2.0-1642296512&partnerID=MN8TOARS.
  178. Matos, O.; Costa, M.C.; Correia, I.; Monteiro, P.; Monteiro, M.; Soares, J.; Vieira, J.R.; Bonnet, M.; Antunes, F.. "Pneumocystis jirovecii Carriage in Portuguese Immunocompetent Patients: Preliminary Results". Journal of Eukaryotic Microbiology 50 SUPPL. (2003): 647-648. http://www.scopus.com/inward/record.url?eid=2-s2.0-0347597025&partnerID=MN8TOARS.
    10.1111/j.1550-7408.2003.tb00668.x
  179. Matos, O.; Lee, C.-H.; Jin, S.; Li, B.; Costa, M.C.; Gonçalves, L.; Antunes, F.. "Pneumocystis jiroveci in Portuguese immunocompromised patients: Association of specific ITS genotypes with treatment failure, bad clinical outcome and childhood". Infection, Genetics and Evolution 3 4 (2003): 281-285. http://www.scopus.com/inward/record.url?eid=2-s2.0-0242558925&partnerID=MN8TOARS.
    10.1016/S1567-1348(03)00092-3
  180. Lobo, M.L.; Teles, A.; Da Cunha, M.B.; Henriques, J.; Lourenço, A.M.; Antunes, F.; Matos, O.. "Microsporidia Detection in Stools from Pets and Animals from the Zoo in Portugal: A Preliminary Study". Journal of Eukaryotic Microbiology 50 SUPPL. (2003): 581-582. http://www.scopus.com/inward/record.url?eid=2-s2.0-0347597086&partnerID=MN8TOARS.
    10.1111/j.1550-7408.2003.tb00638.x
  181. Florence, E.; Lundgren, J.; Dreezen, C.; Fisher, M.; Kirk, O.; Blaxhult, A.; Panos, G.; et al. "Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study". HIV Medicine 4 3 (2003): 255-262. http://www.scopus.com/inward/record.url?eid=2-s2.0-0041631056&partnerID=MN8TOARS.
    10.1046/j.1468-1293.2003.00156.x
  182. Alves, M.; Xiao, L.; Sulaiman, I.; Lal, A.A.; Matos, O.; Antunes, F.. "Subgenotype analysis of Cryptosporidium isolates from humans, cattle, and zoo ruminants in Portugal". Journal of Clinical Microbiology 41 6 (2003): 2744-2747. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037841856&partnerID=MN8TOARS.
  183. Van Leeuwen, R.; Katlama, C.; Murphy, R.L.; Squires, K.; Gatell, J.; Horban, A.; Clotet, B.; et al. "A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients". AIDS 17 7 (2003): 987-999. http://www.scopus.com/inward/record.url?eid=2-s2.0-0038369913&partnerID=MN8TOARS.
    10.1097/00002030-200305020-00007
  184. Costa, M.C.; Gaspar, J.; Ribeiro, C.; Antunes, F.; Matos, O.. "Dihydropteroate Synthase (DHPS) Genotyping by PCR-RFLP Analysis of Pneumocystis jirovecii Repeated Isolates from HIV-Infected Patients: A Preliminary Study". Journal of Eukaryotic Microbiology 50 SUPPL. (2003): 607-608. http://www.scopus.com/inward/record.url?eid=2-s2.0-0346966097&partnerID=MN8TOARS.
    10.1111/j.1550-7408.2003.tb00647.x
  185. Friis-Møller, N.; Sabin, C.A.; Weber, R.; d'Arminio Monforte, A.; El-Sadr, W.M.; Reiss, P.; Thiébaut, R.; et al. "Combination Antiretroviral Therapy and the Risk of Myocardial Infarction: The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group". New England Journal of Medicine 349 21 (2003): 1993-2003. http://www.scopus.com/inward/record.url?eid=2-s2.0-0345064200&partnerID=MN8TOARS.
    10.1056/NEJMoa030218
  186. Alves, M.; Matos, O.; Antunes, F.. "Microsatellite Analysis of Cryptosporidium hominis and C. parvum in Portugal: A Preliminary Study". Journal of Eukaryotic Microbiology 50 SUPPL. (2003): 529-530. http://www.scopus.com/inward/record.url?eid=2-s2.0-0348227639&partnerID=MN8TOARS.
    10.1111/j.1550-7408.2003.tb00619.x
  187. Costa, M.C.; Helweg-Larsen, J.; Lundgren, B.; Antunes, F.; Matos, O.. "Mutations in the dihydropteroate synthase gene of Pneumocystis jiroveci isolates from Portuguese patients with Pneumocystis pneumonia". International Journal of Antimicrobial Agents 22 5 (2003): 516-520. http://www.scopus.com/inward/record.url?eid=2-s2.0-0242384670&partnerID=MN8TOARS.
    10.1016/S0924-8579(03)00122-5
  188. Valadas, E.; Hänscheid, T.; Fernandes, M.L.; Antunes, F.. "Smear microscopy to diagnose tuberculosis early and prevent further transmission in a population with a high prevalence of HIV infection". Clinical Microbiology and Infection 9 10 (2003): 1045-1047. http://www.scopus.com/inward/record.url?eid=2-s2.0-0242300194&partnerID=MN8TOARS.
    10.1046/j.1469-0691.2003.00702.x
  189. Miller, V.; Phillips, A.N.; Clotet, B.; Mocroft, A.; Ledergerber, B.; Kirk, O.; Ormaasen, V.; et al. "Association of virus load, CD4 cell count, and treatment with clinical progression in human immunodeficiency virus-infected patients with very low CD4 cell counts". Journal of Infectious Diseases 186 2 (2002): 189-197. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037099450&partnerID=MN8TOARS.
    10.1086/341466
  190. Blaxhult, A.; Fox, Z.; Colebunders, R.; Francioli, P.; Ben-Ishai, Z.; Fätkenheuer, G.; Parkin, J.M.; et al. "Regional and temporal changes in AIDS in Europe before HAART". Epidemiology and Infection 129 3 (2002): 565-576. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036978310&partnerID=MN8TOARS.
  191. Babiker, A.G.; Andersson, R.; Antunes, F.; Breckenridge, A.; Brosgart, C.; Clezy, K.; Cooper, D.; et al. "A randomized placebo-controlled trial of adefovir dipivoxil in advanced HIV infection: The ADHOC trial". HIV Medicine 3 4 (2002): 229-238. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036813507&partnerID=MN8TOARS.
    10.1046/j.1468-1293.2002.00111.x
  192. Matos, O.; Lobo, M.L.; Gonçalves, L.; Antunes, F.. "Diagnostic use of 3 techniques for identification of microsporidian spores among AIDS patients in Portugal". Scandinavian Journal of Infectious Diseases 34 8 (2002): 591-593. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036040637&partnerID=MN8TOARS.
    10.1080/00365540110080872
  193. Mocroft, A.; Brettle, R.; Kirk, O.; Blaxhult, A.; Parkin, J.M.; Antunes, F.; Francioli, P.; et al. "Changes in the cause of death among HIV positive subjects across Europe: Results from the EuroSIDA study". AIDS 16 12 (2002): 1663-1671. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037119023&partnerID=MN8TOARS.
    10.1097/00002030-200208160-00012
  194. Pereira Da Fonseca, I.; Fazendeiro, I.; Antunes, F.. "Genetic characterization of Cryptosporidium parvum isolates from cattle in Portugal: Animal and human implications". Journal of Eukaryotic Microbiology 48 SUPPL. (2001): http://www.scopus.com/inward/record.url?eid=2-s2.0-0035544848&partnerID=MN8TOARS.
  195. Alves, M.; Matos, O.; Pereira Da Fonseca, I.; Delgado, E.; Lourenço, A.M.; Antunes, F.. "Multilocus genotyping of Cryptosporidium isolates from human HIV-infected and animal hosts". Journal of Eukaryotic Microbiology 48 SUPPL. (2001): http://www.scopus.com/inward/record.url?eid=2-s2.0-0035544841&partnerID=MN8TOARS.
  196. Matos, O.; Lobo, M.L.; Antunes, F.. "Methodology of the diagnosis of microsporidiosis in urine and pulmonary specimens from AIDS patients". Journal of Eukaryotic Microbiology 48 SUPPL. (2001): http://www.scopus.com/inward/record.url?eid=2-s2.0-0035544856&partnerID=MN8TOARS.
  197. Kirk, O.; Pedersen, C.; Cozzi-Lepri, A.; Antunes, F.; Miller, V.; Gatell, J.M.; Katlama, C.; et al. "Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy". Blood 98 12 (2001): 3406-3412. http://www.scopus.com/inward/record.url?eid=2-s2.0-0035760292&partnerID=MN8TOARS.
    10.1182/blood.V98.12.3406
  198. Phillips, A.N.; Pradier, C.; Lazzarin, A.; Clotet, B.; Goebel, F.-D.; Hermans, P.; Antunes, F.; et al. "Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patients". AIDS 15 18 (2001): 2385-2395. http://www.scopus.com/inward/record.url?eid=2-s2.0-0035824773&partnerID=MN8TOARS.
    10.1097/00002030-200112070-00006
  199. Babiker, A.G.; Darbyshire, J.H.; Cooper, D.A.; Hooker, M.H.; Withnall, R.; Yeni, P.; Angarano, G.; et al. "An open-label randomized trial to evaluate different therapeutic strategies of combination therapy in HIV-1 infection: Design, rationale, and methods of the initio trial". Controlled Clinical Trials 22 2 (2001): 160-175. http://www.scopus.com/inward/record.url?eid=2-s2.0-0035071409&partnerID=MN8TOARS.
    10.1016/S0197-2456(00)00123-9
  200. Costa, M.C.; Helweg-Larsen, J.; Antunes, F.; Lungren, B.; Diogo, J.; Matos, O.. "PCR-RFLP analysis of the DHPS gene for the study of resistance of Pneumocystis carinii to sulpha drugs in patients with co-infection PCP/HIV". Journal of Eukaryotic Microbiology 48 SUPPL. (2001): http://www.scopus.com/inward/record.url?eid=2-s2.0-0035544874&partnerID=MN8TOARS.
  201. Alves, M.; Matos, O.; Antunes, F.. "Multilocus PCR-RFLP analysis of Cryptosporidium isolates drom HIV-infected patients from Portugal". Annals of Tropical Medicine and Parasitology 95 6 (2001): 627-632. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034807309&partnerID=MN8TOARS.
    10.1080/00034980120092561
  202. Matos, O.; Costa, M.; Lundgren, B.; Caldeira, L.; Aguiar, P.; Antunes, F.. "Effect of oral washes on the diagnosis of Pneumocystis carinii pneumonia with a low parasite burden and on detection of organisms in subclinical infections". European Journal of Clinical Microbiology and Infectious Diseases 20 8 (2001): 573-575. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034806607&partnerID=MN8TOARS.
    10.1007/s100960100563
  203. Schooley, R.T.; Clumeck, N.; Haubrich, R.; Thompson, M.; Danner, S.A.; Van Der Ende, M.E.; Sereni, D.; et al. "A dose-ranging study to evaluate the antiretroviral activity and safety of amprenavir alone and in combination with abacavir in HIV-infected adults with limited antiretroviral experience". Antiviral Therapy 6 2 (2001): 89-96. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034945256&partnerID=MN8TOARS.
  204. Sousa, A.E.; Chaves, A.F.; Doroana, M.; Antunes, F.; Victorino, R.M.M.. "Bulk cytokine production versus frequency of cytokine-producing cells in HIV1 infection before and during HAART". Clinical Immunology 97 2 (2000): 162-170. http://www.scopus.com/inward/record.url?eid=2-s2.0-0033778273&partnerID=MN8TOARS.
    10.1006/clim.2000.4930
  205. Mocroft, A.; Katlama, C.; Johnson, A.M.; Pradier, C.; Antunes, F.; Mulcahy, F.; Chiesi, A.; et al. "AIDS across Europe, 1994-98: The EuroSIDA study". Lancet 356 9226 (2000): 291-296. http://www.scopus.com/inward/record.url?eid=2-s2.0-0003248215&partnerID=MN8TOARS.
  206. Shanmugam, V.; Switzer, W.M.; Nkengasong, J.N.; García-Lerma, G.; Green, T.A.; Ekpini, E.; Sassan-Morokro, M.; et al. "Lower HIV-2 plasma viral loads may explain differences between the natural histories of HIV-1 and HIV-2 infections". Journal of Acquired Immune Deficiency Syndromes 24 3 (2000): 257-263. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034232749&partnerID=MN8TOARS.
  207. Matos, O.; Lundgren, B.; Caldeira, L.; Mansinho, K.; Aguiar, P.; Forte, M.; Antunes, F.. "Evaluation of two nested polymerase chain reactions for diagnosis of Pneumocystis carinii pneumonia in immunocompromised patients". Clinical Microbiology and Infection 6 3 (2000): 149-152. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034160365&partnerID=MN8TOARS.
    10.1046/j.1469-0691.2000.00044.x
  208. Alves, M.; Matos, O.; Spano, F.; Antunes, F.. "PCR-RFLP analysis of Cryptosporidium parvum isolates from HIV-infected patients in Lisbon, Portugal". Annals of Tropical Medicine and Parasitology 94 3 (2000): 291-297. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034023503&partnerID=MN8TOARS.
    10.1080/00034980050006474
  209. Rodés, B.; Holguín, A.; Soriano, V.; Dourana, M.; Mansinho, K.; Antunes, F.; González-Lahoz, J.. "Emergence of drug resistance mutations in human immunodeficiency virus type 2-infected subjects undergoing antiretroviral therapy". Journal of Clinical Microbiology 38 4 (2000): 1370-1374. http://www.scopus.com/inward/record.url?eid=2-s2.0-0033999842&partnerID=MN8TOARS.
  210. Paredes, R.; Mocroft, A.; Kirk, O.; Lazzarin, A.; Barton, S.E.; Van Lunzen, J.; Katzenstein, T.L.; et al. "Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: Results from the EuroSIDA Study". Archives of Internal Medicine 160 8 (2000): 1123-1132. http://www.scopus.com/inward/record.url?eid=2-s2.0-17744418262&partnerID=MN8TOARS.
  211. Soriano, V.; Gomes, P.; Heneine, W.; Holguín, A.; Doruana, M.; Antunes, R.; Mansinho, K.; et al. "Human immunodeficiency virus type 2 (HIV-2) in Portugal: Clinical spectrum, circulating subtypes, virus isolation, and plasma viral load". Journal of Medical Virology 61 1 (2000): 111-116. http://www.scopus.com/inward/record.url?eid=2-s2.0-16744369116&partnerID=MN8TOARS.
    10.1002/(SICI)1096-9071(200005)61:1<111::AID-JMV18>3.0.CO;2-W
  212. Haubrich, R.; Thompson, M.; Schooley, R.; Lang, W.; Stein, A.; Sereni, D.; Van Der Ende, M.E.; et al. "A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviral experience". AIDS 13 17 (1999): 2411-2420. http://www.scopus.com/inward/record.url?eid=2-s2.0-0032777353&partnerID=MN8TOARS.
    10.1097/00002030-199912030-00013
  213. Aleixo, M.J.; Ferreira, M.L.; Antunes, F.. "Brucellosis - A review,Brucelose". Acta Medica Portuguesa 12 12 (1999): 323-330. http://www.scopus.com/inward/record.url?eid=2-s2.0-0033360981&partnerID=MN8TOARS.
  214. Matos, O.; Lundgren, B.; Caldeira, L.; Mansinho, K.; Aguiar, P.; Forte, M.; Antunes, F.. "Evaluation of a nested PCR for detection of Pneumocystis carinii in serum from immunocompromised patients". Journal of Eukaryotic Microbiology 46 5 (1999): http://www.scopus.com/inward/record.url?eid=2-s2.0-0033198394&partnerID=MN8TOARS.
  215. Sousa, A.E.; Chaves, A.F.; Doroana, M.; Antunes, F.; Victorino, R.M.M.. "Kinetics of the changes of lymphocyte subsets defined by cytokine production at single cell level during highly active antiretroviral therapy for HIV-1 infection". Journal of Immunology 162 6 (1999): 3718-3726. http://www.scopus.com/inward/record.url?eid=2-s2.0-0033559879&partnerID=MN8TOARS.
  216. Gomes, P.; Taveira, N.C.; Moniz Pereira, J.; Antunes, F.; Santos Ferreira, M.O.; Lourenço, M.H.. "Quantitation of human immunodeficiency virus type 2 DNA in peripheral blood mononuclear cells by using a quantitative-competitive PCR assay". Journal of Clinical Microbiology 37 2 (1999): 453-456. http://www.scopus.com/inward/record.url?eid=2-s2.0-0345683492&partnerID=MN8TOARS.
  217. Matos, O.; Lundgren, B.; Aguiar, P.; Costa, M.; Antunes, F.. "Comparison of four methods for extraction of Pneumocystis carinii DNA from pulmonary specimens and serum". Journal of Eukaryotic Microbiology 46 5 (1999): http://www.scopus.com/inward/record.url?eid=2-s2.0-0033199224&partnerID=MN8TOARS.
  218. Grüneberg, R.N.; Antunes, F.; Chambers, H.F.; Garau, J.; Graninger, W.; Menichetti, F.; Peetermans, W.E.; et al. "The role of glycopeptide antibiotics in the treatment of infective endocarditis". International Journal of Antimicrobial Agents 12 3 (1999): 191-198. http://www.scopus.com/inward/record.url?eid=2-s2.0-0345104434&partnerID=MN8TOARS.
    10.1016/S0924-8579(99)00006-0
  219. Sousa, A.E.; Chaves, A.F.; Doroana, M.; Antunes, F.; Victorino, R.M.M.. "Early reduction of the over-expression of CD40L, OX40 and Fas on T cells in HIV-1 infection during triple anti-retroviral therapy: Possible implications for lymphocyte traffic and functional recovery". Clinical and Experimental Immunology 116 2 (1999): 307-315. http://www.scopus.com/inward/record.url?eid=2-s2.0-0032894849&partnerID=MN8TOARS.
    10.1046/j.1365-2249.1999.00872.x
  220. Miller, V.; Mocroft, A.; Reiss, P.; Katlama, C.; Papadopoulos, A.I.; Katzenstein, T.; Van Lunzen, J.; et al. "Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: Results from the EuroSIDA Study". Annals of Internal Medicine 130 7 (1999): 570-577. http://www.scopus.com/inward/record.url?eid=2-s2.0-0033528735&partnerID=MN8TOARS.
  221. Kirk, O.; Mocroft, A.; Katzenstein, T.L.; Lazzarin, A.; Antunes, F.; Francioli, P.; Brettle, R.P.; et al. "Changes in use of antiretroviral therapy in regions of Europe over time". AIDS 12 15 (1998): 2031-2039. http://www.scopus.com/inward/record.url?eid=2-s2.0-7844246144&partnerID=MN8TOARS.
  222. Matos, O.; Tomás, A.; Aguiar, P.; Casemore, D.; Antunes, F.. "Prevalence of cryptosporidiosis in AIDS patients with diarrhoea in Santa Maria Hospital, Lisbon". Folia Parasitologica 45 2 (1998): 163-166. http://www.scopus.com/inward/record.url?eid=2-s2.0-0031851678&partnerID=MN8TOARS.
  223. Campino, L.; Santos-Gomes, G.M.; Pratlong, F.; Antunes, F.; Maurício, I.; Dedet, J.P.; Abranches, P.. "HIV/Leishmania co-infections in Portugal: Diagnosis and isoenzyme characterization of Leishmania". Annals of Tropical Medicine and Parasitology 91 4 (1997): 433-436. http://www.scopus.com/inward/record.url?eid=2-s2.0-0030876670&partnerID=MN8TOARS.
    10.1080/00034989761067
  224. Antunes, F.. "The role of general practitioners in the control of HIV infection and in the treatment of seropositive and AIDS patients,O papel dos clínicos gerais no controlo da infecção VIH e no tratamento dos seropositivos e dos doentes com SIDA.". Acta médica portuguesa 10 6-7 (1997): 485-486. http://www.scopus.com/inward/record.url?eid=2-s2.0-0031157672&partnerID=MN8TOARS.
  225. Pittet, D.; Menichetti, F.; Antunes, F.; Garau, J.; Graninger, W.; Grüneberg, R.N.; Peetermans, W.E.; Shah, P.M.. "Empirical antibacterial treatment for sepsis and the role of glycopeptides: Recommendations from a European panel". Clinical Microbiology and Infection 3 3 (1997): 273-282. http://www.scopus.com/inward/record.url?eid=2-s2.0-0030744448&partnerID=MN8TOARS.
  226. Antunes, F.. "Emerging and spreading infectious diseases,Doenças infecciosas emergentes e em expansão.". Acta médica portuguesa 10 6-7 (1997): 427-428. http://www.scopus.com/inward/record.url?eid=2-s2.0-0031160233&partnerID=MN8TOARS.
  227. Balslev, U.; Monforte, A.D.; Stergiou, G.; Antunes, F.; Mulcahy, F.; Pehrson, P.O.; Phillips, A.; Pedersen, C.; Lundgren, J.D.. "Influence of age on rates of new AIDS-defining diseases and survival in 6546 AIDS patients". Scandinavian Journal of Infectious Diseases 29 4 (1997): 337-343. http://www.scopus.com/inward/record.url?eid=2-s2.0-0347833011&partnerID=MN8TOARS.
    10.3109/00365549709011827
  228. Gatell, J.M.; González-Lahoz, J.; Clotet, B.; Antunes, F.; Kasparova, L.; Gil-Aguado, A.; Saballs, P.; et al. "Switching from zidovudine to didanosine in patients with symptomatic HIV infection and disease progression". Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 12 3 (1996): 249-258. http://www.scopus.com/inward/record.url?eid=2-s2.0-1542429700&partnerID=MN8TOARS.
  229. Pedersen, C.; Danner, S.; Lazzarin, A.; Glauser, M.P.; Weber, R.; Katlama, C.; Barton, S.E.; et al. "Epidemiology of cryptosporidiosis among European AIDS patients". Sexually Transmitted Infections 72 2 (1996): 128-131. http://www.scopus.com/inward/record.url?eid=2-s2.0-79960386376&partnerID=MN8TOARS.
    10.1136/sti.72.2.128
  230. Chiesi, A.; Vella, S.; Dally, L.G.; Pedersen, C.; Danner, S.; Johnson, A.M.; Schwander, S.; et al. "Epidemiology of AIDS dementia complex in Europe". Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 11 1 (1996): 39-44. http://www.scopus.com/inward/record.url?eid=2-s2.0-1542744960&partnerID=MN8TOARS.
  231. Kinloch-de Loã«s, S.; Hirschel, B.J.; Hoen, B.; Cooper, D.A.; Tindall, B.; Carr, A.; Saurat, J.-H.; et al. "A Controlled Trial of Zidovudine in Primary Human Immunodeficiency Virus Infection". New England Journal of Medicine 333 7 (1995): 408-413. http://www.scopus.com/inward/record.url?eid=2-s2.0-0029097463&partnerID=MN8TOARS.
    10.1056/NEJM199508173330702
  232. Phillips, A.N.; Antunes, F.; Stergious, G.; Ranki, A.; Jensen, G.F.; Bentwich, Z.; Sacks, T.; et al. "A sex comparison of rates of new AIDS-defining disease and death in 2554 AIDS cases". AIDS 8 6 (1994): 831-835. http://www.scopus.com/inward/record.url?eid=2-s2.0-0028357509&partnerID=MN8TOARS.
  233. Brito, D.A.; Lacerda, A.P.; Fernandes, P.; Metrass, M.J.; de Pádua, F.; Antunes, F.; Madeira, H.C.. "Human immunodeficiency virus infection and systolic myocardial performance". International Journal of Angiology 3 1 (1994): 148-153. http://www.scopus.com/inward/record.url?eid=2-s2.0-34249765145&partnerID=MN8TOARS.
    10.1007/BF02014934
  234. Brito, D.A.; Lacerda, A.P.; Fernandes, P.; Metrass, M.J.; de Pádua, F.; Antunes, F.; Madeira, H.C.. "Human immunodeficiency virus infection and systolic myocardial performance". International Journal of Angiology 3 1 (1994): 148-153. http://www.scopus.com/inward/record.url?eid=2-s2.0-85024772667&partnerID=MN8TOARS.
    10.1055/s-0031-1275921
  235. Atalaia, A.; Ferrol, J.; Antunes, F.. "Stroke in an HIV-infected patient". Journal of Neurology 239 6 (1992): 356-357. http://www.scopus.com/inward/record.url?eid=2-s2.0-0026700983&partnerID=MN8TOARS.
    10.1007/BF00867598
  236. Antunes, F.. "Therapeutic perspectives of infection by HIV and of opportunist infections. Multicentre clinical research programmes in the EEC,PERSPECTIVAS TERAPEUTICAS DA INFECCAO PELO VIH E DAS INFECCOES OPORTUNISTAS. PROJECTOS DE INVESTIGACAO CLINICA MULTICENTRICOS NA CEE". Acta Medica Portuguesa 4 SUPPL. 1 (1991): 67-68. http://www.scopus.com/inward/record.url?eid=2-s2.0-0026333550&partnerID=MN8TOARS.
  237. Antunes, F.. "AIDS: Health care management in hospitals,SIDA: A DOENCA E A PRESTACAO DE CUIDADOS DE SAUDE HOSPITALARES". Acta Medica Portuguesa 2 6 (1989): 241-243. http://www.scopus.com/inward/record.url?eid=2-s2.0-0024763128&partnerID=MN8TOARS.
  238. Antunes, F.; Carvalho, C.; Tavares, L.; Botas, J.; Forte, M.; del Rio, A.M.; Dutschmann, L.; et al. "Visceral leishmaniasis recrudescence in a patient with AIDS". Transactions of the Royal Society of Tropical Medicine and Hygiene 81 4 (1987): http://www.scopus.com/inward/record.url?eid=2-s2.0-0023477334&partnerID=MN8TOARS.
  239. Antunes, F.; Forte, M.; Tavares, L.; Botas, J.; Carvalho, C.; Carmona, H.; Araujo, F.C.. "Malaria in Portugal 1977-1986". Transactions of the Royal Society of Tropical Medicine and Hygiene 81 4 (1987): 561-562. http://www.scopus.com/inward/record.url?eid=2-s2.0-0023504455&partnerID=MN8TOARS.
  240. Antunes, F.. "Antibiotic therapy of odontogenic infections,A antibioterapia nas infecções odontogénicas.". Revista portuguesa de estomatologia e cirurgia maxilo-facial 25 1 (1984): 631-640. http://www.scopus.com/inward/record.url?eid=2-s2.0-18344409601&partnerID=MN8TOARS.
Capítulo de livro
  1. Matos, O.; Tomás, A.L.; Antunes, F.. "Pneumocystis jirovecii and pneumocystosis". 215-254. 2017.
Atividades

Orientação

Título / Tema
Papel desempenhado 		Curso (Tipo)
Instituição / Organização
2017 - 2017 Infecção oculta por vírus da hepatite B em doentes com anti-HBc isolado e coinfecção por vírus da imunodeficiência humana, Maputo, Moçambique
Orientador
 Doenças Infecciosas Emergentes (Mestrado)
Universidade de Lisboa Faculdade de Medicina, Portugal
2016 - 2016 Estudo da diversidade genética e da resistência primária a lamivudina de vírus da hepatite B em co-infectados por vírus da imunodeficiência humana, em Maputo , Moçambique
Orientador
 Doenças Infecciosas Emergentes (Mestrado)
Universidade de Lisboa Faculdade de Medicina, Portugal
2006 - 2006 Caracterização Epidemiológica da Criptosporidiose em Portugal, por Estudo Molecular de Isolados de Cryptosporidium Spp. de Humanos e Animais
Orientador
 Ciências Biomédicas (Doutoramento)
Universidade Nova de Lisboa Instituto de Higiene e Medicina Tropical, Portugal

Curso / Disciplina lecionado

Disciplina Curso (Tipo) Instituição / Organização
2021/11 - 2024/04 One health course: human health, animal health and environmental health (Pós-Graduação) Faculdade de Medicina da Universidade de Lisboa, Portugal
2021/10 - 2024/04 Infeccious diseases post-graduate course (Pós-Graduação)